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Abstract 
Micropollutants are emerging as a new challenge to the scientific community. This review 
provides a summary of the recent occurrence of micropollutants in the aquatic 
environment including sewage, surface water, groundwater and drinking water. The 
discharge of treated effluent from WWTPs has been a major pathway for the introduction of 
micropollutants to surface water. WWTPs act as primary barriers against the spread of 
micropollutants. WWTP removal efficiency of the selected micropollutants in 14 
countries/regions depicts compound-specific variation in removal, ranging from 12.5 to 100%. 
Biodegradation is a significant removal pathway for some pharmaceuticals and steroid 
hormones but of minor importance for antibiotics and pesticides. Sorption serves as the main 
removal mechanism for industrial chemicals and musks. Advanced treatment processes, such 
as activated carbon adsorption, advanced oxidation processes, reverse osmosis, and 
membrane bioreactors can achieve higher and more consistent micropollutantds removal. 
However, no matter what technology is employed, the removal of micropollutants depends on 
phsyico-chemical properties of micropollutants and the treatment conditions. Additionally, a 
better monitoring of micropollutants in surface waters is essential for effectively predicting 
micropollutants’ impacts on the receiving environment.  
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Over the last few decades, the occurrence of micropollutants in the aquatic environment 
has become a worldwide issue of increasing environmental concern. Micropollutants, also 
termed as emerging contaminants, consist of a vast and expanding array of anthropogenic as 
well as natural substances. These include pharmaceuticals, personal care products, steroid 
hormones, industrial chemicals, pesticides and many other emerging compounds. 
Micropollutants are commonly present in waters at trace concentrations, ranging from a few 
ng/L to several µg/L. The ‘low concentration’ and diversity of micropollutants not only 
perplexes the associated detection and analysis procedures but also creates challenges for 
water and wastewater treatment processes.  
Current wastewater treatment plants (WWTPs) are not specifically designed to eliminate 
micropollutants. Thus, many of these micropollutants are able to pass through wastewater 
treatment processes by virtue of their persistency or/and the continuous introduction. In 
addition, precautions and monitoring actions for micropollutants have not been well 
established in most WWTPs (Bolong et al., 2009). Consequently, many of these compounds 
may end up in the aquatic environment, becoming threats to wildlife and spelling trouble for 
drinking water industry. The occurrence of micropollutants in the aquatic environment have 
been frequently associated with a number of negative effects, including short-term and long-
term toxicity, endocrine disrupting effects and antibiotic resistance of microorganisms (Fent 
et al., 2006; Pruden et al., 2006). To date, discharge guidelines and standards do not exist for 
most micropollutants. To set regulatory limits for micropollutants, further research on 
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biological responses to these compunds (both short-term and long-term effects) is of 
particular importance. Futhermore, the scientific and regulatory communities should give 
insight into not only the impact of individual micropollutant, but also their synergistic and 
antagonistic effects (Bhandari, 2009). 
Several review papers have been published with regard to the occurrence of 
micropollutants in different water bodies such as wastewater (Deblonde et al., 2011) and 
groundwater (Lapworth et al., 2012), as well as treatment methods for micropollutant 
removal (Bolong et al., 2009). In addition, Verlicchi et al. (2012) reviewed the 
pharmaceutical removal efficiency in conventional activated sludge systems and in MBR fed 
by municipal wastewater, while Ze-hua Liu et al. (2009) focused on the physical, chemical 
and biological removal of endocrine disrupting compounds (EDCs). However, no attempt has 
been made to provide a comprehensive summary of the occurrence of miscellaneous 
micropollutants in aquatic systems as well as  the removal of micropollutants in conventional 
and advanced treatment processes. In this review, we  systematically summarized the recent 
occurrence of various micropollutants in the aquatic environment and delineated the 
behaviour and removal of micropollutants during conventional as well as advanced 
wastewater treatment processes. 
 
2. Occurrence of micropollutants in the aquatic environment 
 
Sources of micropollutants in the environment are diverse and many of these originate 
from mass-produced materials and commodities. Table 1 summarizes the source categories of 
some major micropollutants in aquatic ecosystem. Figure 1 illustrates the possible routes for 





The recent occurrence (2008 to date) of the micropollutants in the aquatic environment 
has been reviewed in terms of their aqueous concentrations in different types of waters, 
including wastewater, surface waters, groundwater and drinking water. Of all aqueous media, 
WWTP influent and effluent are comprehensively reviewed. The collected data consist of the 
studies performed in a number of countries/regions, including Austria, China, EU-wide, 
France, Germany, Greece, Italy, Korea, Spain, Sweden, Switzerland, Western Balkan Region, 
UK and US. In general, micropollutants can be divided into six categories namely 
pharmaceuticals, personal care products (PPCPs), steroid hormones, surfactants, industrial 
chemicals and pesticides. 
 
2.1 Occurrence of micropollutants in WWTPs 
Occurrence data of micropollutants in WWTP influent and effluent from recent studies 
(2008present) are summarized in Table 2. As can be noted from the table, the reported 
concentrations of micropollutants in WWTP influent and effluent reveal significant spatial 
and temporal variations, which are essentially due to a number of factors, including the rate 
of production, specific sales and practices, metabolism (excretion rate), water consumption 
per person and per day, the size of WWTPs, environmental persistence and elimination 
efficacy of wastewater treatment processes (Petrovic et al., 2009; Jelic et al, 2012). 
Table 2 
The local production and usage/consumption of products containing micropollutants 
determine the amount of micropoullutants reaching WWTPs. Studies suggested that PPCP 
concentrations in wastewater correlated well with their production amounts and 
usage/consumption patterns. Choi et al. (2008a) reported that the occurrence concentrations 
of acetaminophen, carbamazepine, cimetidine, diltiazem, sulfamethoxazole and trimethoprim 
followed the same order (from highest to lowest) of their annual production amount in Korea. 
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High concentrations (>10 µg/L) of paracetamol, tramadol, codeine, gabapentin and atenolol 
were detected at highest levels in raw wastewater in Wales, UK and this could be explained 
by the high quantities of these pharmaceuticals dispensed (Kasprzyk-Hordern et al., 2009). 
As orally ingested products containing potential contaminants (e.g. pharmaceuticals) are 
metabolized in human body and are subsequently excreted via urine and feces, excretion rate 
plays a role in determining the introduction of pharmaceuticals into raw wastewater. Table 3 
presents the excretion rates for some commonly encountered pharmaceuticals. It can be noted 
that pharmaceutical compounds with low excretion rates (e.g., ibuprofen, carbamazepine, 
sulfamethoxazole, diclofenac and primidione) are not necessarily present at low levels in the 
raw wastewater. This is possibly because the low excretion rates are offset by the massive use 
of these compounds. In addition, local common diseases can induce a higher consumption of 
specific pharmaceuticals in certain periods. Research showed climatic conditions could cause 
fluctuating micropollutant input (Kolpin et al., 2004). For instance, the use of pesticides can 
be seasonal due to the prevalence of pests in different climatic conditions. Another important 
factor is rainfall, as it affects the flow pattern of wastewater influent when a combined sewer 
system is employed. Kasprzyk-Hordern et al. (2009) found that the concentrations of most 
PPCPs in the raw wastewater were doubled when the flow was halved during dry weather 
conditions, suggesting that rainwater could dilute the concentration of the compounds within 
the sewage.  Other weather conditions, such as temperature and level of sunlight also can 
affect the discharge of micropollutants from WWTPs.  
Table 3 
Occurrence levels of some of the most studied compounds in WWTP influent and 
effluent are presented in Fig. 2. As can be seen in Fig. 2, most micropollutants occurred in 
WWTP influent in the concentration range from 0.1 to 10 µg/L, while some pharmaceutical 
compounds (acetaminophen, caffeine, ibuprofen, naproxen and salicylic acid), a biocide 
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(triclosan), one surfactant (Nonylphenol) and one industrial chemicals (DEHP) exhibit 
relatively higher occurrence concentration. Generally, the compounds with the highest 
concentrations (mean values > 10 µg/L) in WWTP influent were ibuprofen, atenolol, caffeine 
and nonylphenol. For instance, ibuprofen was the most abundant compound detected in the 
influent of four WWTPs in Spain, with the concentration levels ranging from 3.73 to 603 
µg/L (Santos et al., 2009). The particularly high levels could be explained by the high 
consumption and easy accessibility (over the counter drugs) of the compound (Camacho-
Muñoz et al., 2010). Caffeine was detected at the highest levels approaching 50 µg/L on 
average in raw sewage in three WWTPs in China (Zhou et al., 2010). The abundant presence 
of caffeine is likely associated with the high consumption of coffee, tea and soft drinks as 
well as the disposal of these items. Steroid hormones and pesticides generally exhibit lower 
detected concentrations (mostly less than 1 µg/L) as compared with compounds from other 
groups. The concentrations of most micropollutants in effluent ranged from 0.001 to 1 µg/L, 
which were one to two orders of magnitude lower than those in influent. Some abundant 
compounds in influent were discharged at relatively high concentrations. For instance, 
atenolol, caffeine, DEHP, ibuprofen, naproxen, nonylphenol and triclosan were detected in 
the concentrations higher than 1 µg/L in treated effluent. In contrast, steroid hormones were 
found in wastewater at much lower levels (<100 ng/L). However, their occurrence even at 
low concentrations is a concern because of their high estrogenic effect. 
Fig. 2. 
 
2.2 Occurrence of micropollutants in surface water 
The release of WWTP effluent into surface water has been considered as a main cause of 
the presence of micropollutants in surface water in comparison to other sources (Kasprzyk-
Hordern et al., 2009). Following treatment processes in WWTPs, micropollutants are 
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subjected to varying degrees of natural attenuation (e.g., dilution in surface water, sorption 
onto suspended solids and sediments, direct and indirect photolysis and aerobic 
biodegradation) (Pal et al., 2010). Due to river water dilution, pharmaceutical compounds 
may occur at levels at least one order of magnitude lower than effluent levels (Gros et al., 
2007). Gómez et al. (2012) found that the natural attenuation of PCPs is more likely to result 
from river water dilution, or sorption to solids, than from degradation. Furthermore, river 
water dilution can be affected by rainfall. Consistent increase in micropollutant occurrence 
levels during dry weather conditions and marked reduction during wet weather conditions 
have been reported. Wang et al. (2011) indicated that pharmaceuticals in summer water 
samples showed lower occurrence levels than those in winter. This could be due to 1) 
promoted biodegradation of pharmaceuticals in warmer temperature, and 2) elevated dilution 
during wetter summer. However, rainfall did not always reduce the concentration levels of 
micropollutants released. In some cases, rainfall was identified as a contributor to the 
emission of micropollutants to surface water. Some studies revealed that the chemicals (e.g., 
bisphenol A and biocides) used in building material (e.g. pavement materials, facades and 
roof paintings) were able to leach during precipitation and accumulate to remarkable levels in 
roof runoff and subsequently ended up in surface water (Sakamoto et al., 2007; Jungnickel et 
al., 2008; Schoknecht et al., 2009; Singer et al., 2010). In addition, rainfall events could 
intensify combined sewer overflows, resulting in a higher level of contaminant discharge.  
According to Table 4 showing common micropollutants in surface water from different 
countries, nonsteroidal anti-inflammatory drugs (NSAIDs), carbamazepine, sulfamethoxazole 
and triclosan were the most frequently reported compounds in surface water. The high 
concentrations of micropollutants were found in Costa Rica, which mainly resulted from the 
discharge of hospital effluents and other highly contaminated waters (Spongberg et al., 2011). 
Notably, ibuprofen, ketoprofen, gemfibrozil and caffeine were detected at alarmingly high 
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levels, with maximum concentrations of 36.8, 9.8, 17.0 and 1121.4 µg/L, respectively. 
Caffeine was also detected at relatively high concentrations in US (224.8 ng/L) and Taiwan 
(1813 ng/L). Unlike Costa Rica, the reported caffeine concentrations in US and Taiwan were 
far below the predicted no effect concentrations (PNECs). Hence, the pollution of emerging 
contaminants in the natural water bodies of the densely populated regions may be more 
severe because of the massive usage of these chemicals by the large population. For example, 
the concentrations of nonylphenol, bisphenol A and triclosan in the surface water of 
Guangzhou (one of the largest cities in China) were rather high, and nonylphenol was also 
found at relatively high concentrations in a Greek river, with a maximum of 2704 ng/L. It is 
noteworthy that the maximum nonylphenol concentrations in China and Greece were well 
above the reported PNEC for nonylphenol. Besides, population aging has also been linked to 
the high occurrence levels of pharmaceuticals (Al-Rifai et al., 2007). 
Table 4 
 
2.3 Occurrence of micropollutants in groundwater 
In comparison to surface water, ground water was found to be less contaminated with 
micropollutants (Loos et al., 2010; Vulliet and Cren-Olivé, 2011). Hence, the presence of 
micropollutants in groundwater has been put far less emphasis on. Better characterization of 
micropollutants in groundwater has been only done regionally (mainly in some parts of 
Europe and North America). Micropollutant contamination of groundwater mainly results 
from landfill leachate, groundwater-surface water interaction, infiltration of contaminated 
water from agricultural land or seepage of septic tanks and sewer systems. Concentrations of 
micropollutants in landfill leachate and septic tank leakage generally range from 10 to 104 
ng/L and 10 to 103 ng/L, respectively (Lapworth et al., 2012). Micropollutants can also be 
introduced in groundwater via bank filtration or artificial recharge using reclaimed water 
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(Stepien et al., 2013). Normally, the processes governing subsurface flow and transport (such 
as dilution, adsorption to aquifer material, degradation and travel time) can decrease 
micropollutants’ concentrations from the sources (e.g., landfill leachate and septic tank 
leakage) to groundwater (Teijon et al., 2010). The physicochemical properties of 
micropollutants are therefore important for the transfer of the compounds to groundwater. For 
example, Octanol-Water partition coefficient Kow indicates contaminant mobility in the 
subsurface, where the compounds (e.g, trimethoprim and TCEP) with Kow < 1.5 tend to stay 
in the dissolved phase (more mobility) and are more likely to occur in groundwater 
(Dougherty et al., 2010; Karnjanapiboonwong et al., 2011). In a study conducted in US, Fram 
and Belitz (2011) found good correlation of pharmaceutical levels in groundwater and 
presence of modern water (water recharged since 1953), occurrence of other synthetic 
contaminants (urban-use herbicides and insecticides and volatile organic compounds) and 
land application.  
For selected countries (Table 5), most of the compounds were detected at less than 100 
ng/L in groundwater. NASIDs, carbamazepine, sulfamethoxazole, caffeine and triclosan were 
of particular research interest. These compounds were also the most commonly detected ones 
in surface water and wastewater, evidencing a correlation of the presence of micropollutants 
in different aquatic systems. By comparing the occurrence concentrations of micropollutants 
with PNEC, most of the compounds were at levels without potential environmental 
significance. However, considerably high concentrations (2 or 3 orders of magnitude higher 
than PNEC) of steroid hormones were found in groundwater at a US land application site 
(Karnjanapiboonwong et al., 2011). The problem probably resulted from the application of 
wastewater effluent to a portion of the soil. Although the authors did not point out the adverse 
effects of the high-level steroid hormones, their occurrence would be of potential concern if 





2.4 Occurrence of micropollutants in drinking water 
A small mass of is available with regard to the occurrence of micropollutants in drinking 
water (Vulliet et al., 2011). Some recent studies showed that most micropollutants in finished 
waters from drinking water treatment were below limit of quantitation or limit of detection 
(Benotti et al., 2008, Huerta-Fontela et al., 2011, Kleywegt et al. 2011, Wang et al., 2011). 
Therefore, only the data of the most abundant compounds have been presented in Figure 3. 
To date, there has been a lack of guidelines for risk assessment for the presence of most 
micropollutants in drinking water. PNEC values were plotted to superficially describe the 
potential of negative effects (Figure 3). The occurrence levels of micropollutants in drinking 
water were dependent on water sources and seasons, with winter water samples showing 
higher concentrations in comparing to summer water samples. Furthermore, drinking water 
treatment plays a significant role in eliminating micropollutants from drinking water and has 
therefore been comprehensively examined (Stackelberg et al., 2004; Westerhoff et al., 2005). 
As can be seen in Figure 3, the maximum occurrence concentrations of most 
micropollutants were reported to be below 100 ng/L, with the exception of carbamazepine 
and caffeine. Notably, carbamazepine was observed at a concentration exceeding 600 ng/L (a 
concentration more than 10 times higher than those of most other compounds) in the study 
conducted by Kleywegt et al. (2011). The high levels of carbamazepine could be explained 
by its high persistency. Even so, the occurrence level of carbamazepine was far below the 
PNEC (25000 ng/L). It is also noteworthy that nonylphenol showed a maximum 
concentration (100 ng/L) most close to PNEC (330 ng/L, less than 1 order of magnitude). 
Other compounds were all at safe levels, since the PNEC values were 2 to 5 orders of 
magnitude higher than the their maximum concentrations. Overall, based on the studies 
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reviewed here, these countries were all able to rule out the adverse impacts of selected 
micropollutants on drinking water. Nevertheless, since other compounds as well as 
transformation by-products, which can also pose adverse effects, were not monitored in these 
studies, the safety of the produced drinking water still needs to be under scrutiny. 
Fig. 3.  
 
3. The removal and fate of micropollutants in WWTPs 
Municipal WWTPs are designed to control a wide range of substances, such as 
particulates, carbonaceous substances, nutrients and pathogens. While these substances can 
be efficiently and consistently removed, the removal of micropollutants is basically under no 
control. Hence, the evaluation of the fate and removal of micropollutants during wastewater 
treatment is imperative for the optimization of treatment processes, in order to prevent the 
release of these potentially harmful micropollutants.  
 
3.1 The fate of micropollutants in WWTPs 
Wastewater treatment plants generally employ a primary, a secondary and an optional 
tertiary treatment process. Tertiary treatment processes are commonly used to produce higher 
quality of discharged water for certain purposes (e.g. water reuse), which are always 
associated with high treatment cost. Thus, the requirement for tertiary treatment processes is 
generally based on public and environmental health objectives. 
Primary treatment processes aims to remove suspended solids that enter WWTPs. 
Micropollutants are removed mainly by sorption on primary sludge, as distribution of a 
compound into organic (lipophilic) layer is a predominant way of sorption (Ternes et al., 
2004). Fragrances (galaxolide and tonalide) were found to be well removed (40%) during 
primary treatment (aerated grit chamber followed by circular sedimentation tank) due to their 
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high partition coefficients between the solid and liquid phase (Carballa et al., 2004). Primary 
treatment (sedimentation tank) was also able to remove some EDCs moderately with removal 
efficiency ranging from 13% (nonylphenol monoethoxylate) to 43% (Bisphenol A) 
(Stasinakis et al., 2013). However, primary treatment using aerated grit chamber could cause 
significant increase of phenolic compounds, such as bisphenol A and nonylphenol, because 
the compounds originally attached to the grits could be peeled off due to air agitation in grit 
chamber (Nie et al., 2012). For pharmaceuticals and hormones, removal efficiency in primary 
treatment ranged up to only 28% (diclofenac and estriol), which suggested that adsorption of 
investigated compounds to sludge particles was rather limited (Behera et al., 2011). No 
considerable reduction was also reported for ibuprofen, naproxen, sulfamethoxazol and 
estrone (Carballa et al., 2004).  
In secondary treatment, micropollutants are subjected to a range of processes, including 
dispersion, dilution, partition, biodegradation and abiotic transformation. The total removal 
during secondary treatment generally refers to the losses of a parent compound contributed 
by different mechanisms of chemical and physical transformation, biodegradation and 
sorption to solids (Jelic et al., 2011). Biodegradation/biotransformation and sorption are the 
two major removal mechanisms during biological treatment, while volatilisation occurs to a 
minor degree (Verlicchi et al., 2012).  
During secondary treatment, micropollutants are biologically degraded to various 
degrees, resulting in mineralisation or incomplete degradation (production of by-products). 
Biodegradation of micropollutants can occur via different mechanisms: 1) single substrate 
growth of a small subset of specialist oligotrophic organisms, which is less common in 
WWTPs and more likely to occur in receiving water or sediment (Daughton and Ternes, 
1999); 2) co-metabolism, in which micropollutants are decomposited by enzymes generated 
for other primary substation degradation (e.g. ammonia monooxygenase (AMO)) and are not 
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used as carbon and energy source for microbial growth; and 3) mixed substrate growth, in 
which micropollutants are used as carbon and energy souce and become mineralized (Vader 
et al., 2000). For pharmaceuticals, even if the compounds fall into the same therapeutical 
group, their biodegradability can show great variability. For example, Salgado et al. 2012 
reported, among NSAIDs, diclofenac exhibited low (<25%) biodegradation, whereas 
ibuprofen and ketoprofen were biodegradated to a much higher extent (>75%). Anticbiotics 
are generally not readily biodegradable (Verlicchi et al., 2012). Regarding polycyclic musk, 
Clara et al., (2011) indicated biological degradation serves as a minor removal pathway. 15% 
and 30% of galaxolide and tonalide were found to be eliminated via biological transformation 
(Salgado et al., 2012). In contrast, Suarez et al., (2010) reproted much higher biodegradation 
of tonalide and galaxolide (>75%). As for steroid hormones, significant biodegradation 
(>75%) was observed for estrone and estradiol (Suarez et al., 2010). Bisphenol A and 
triclosan were also found to be susceptible to biodegradation (up to 85% and 81% 
respectively), while nonylphenol was biologically transformed to a lesser degree (up to 56%) 
in two WWTPs using activated sludge (Samaras et al., 2013). In the case of pesticide, 
Stasinakis et al. (2009) found almost 60% of diuron was biodegraded during a activated 
sludge process.  
Sorption of micropollutants mainly occurs by (1) absorption, in which hydrophobic 
interactions occur between the aliphatic and aromatic groups of a compound and the 
lipophilic cell membrane of microorganisms as well as the fat fractions of sludge, and (2) 
adsorption, involving the electrostatic interactions of the positively charged groups with the 
negatively charged surfaces of the microorganisms and sludge (e.g. amino groups) (Ternes et 
al., 2004). Verlicchi et al. (2012) found that sorption onto solids is insignificant (<5% in most 
cases) for most pharmaceuticals. In a study, mefenamic acid showed about 30% sorption 
(Jelic et al., 2011). In contrast, it was the major removal mechanism for some compounds, 
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such as diclofenac, galaxolide, tonalide (Clara et al., 2011; Salgado et al., 2012). 
Nonylphenol (35% to 51%) and triclosan (11% to 41%) were detected to be moderately 
removed via sorption to solids, while some acidic compounds (e.g., ibuprofen) could not be 
sorbed because of the charge repulsion between solids and compounds (Samaras et al., 2013). 
The compounds that tend to be sorbed onto solids are expected to be better eliminated by 
activated sludge treatment than other low-cost secondary treatments (trickling fiter beds, 
anaerobic lagoon and constructed wet lands) (Camacho-Muñoz et al., 2012). This can be due 
to the promoted biodegradation under forced aeration during the conventional treatments, 
together with the enhanced sorption by large amounts of sludge generated in conventional 
treatment systems.  
In WWTPs, there are circumstances where the effluent concentrations of some 
micropollutants exceed their influent concentrations. This can be explained by the presence 
of some substances, e.g. human metabolites and/or transformation products in the influent, 
which can subsequently be transformed back to parent compounds during biological 
treatment (e.g. diclofenac, carbamazepine, erythromycin, and sulfamethoxazole) (Göbel et al., 
2007; Kasprzyk-Hordern et al., 2009). In addition, some pharmaceuticals excreted with feces 
are probably partly enclosed in feces particles and released during biological treatment. The 
negative removal has also been ascribed to the daily concentration fluctuations during the 
sampling period, the  analytical uncertainty, or desorption of molecules from sludge and 
suspended particulate matter (Clara et al., 2004; Köck-Schulmeyer et al., 2013).  
3.1 Overall removals of micropollutants in conventional WWTPs 
The term “overall removal” generally refers to all the losses of micropollutant parent 
compounds from aqueous phase. Figure 4 showing the WWTP removal efficiency of the 
most studied micropollutants in 14 countries/regions (data from Table 2) depicts compound-
specific variation in removal (12.5 to 100%). Compounds even in the same usage class were 
15 
 
removed to fairly different degrees. For individual compounds, location-specific large 
elimination disparities were also displayed. For example, diclofenac was significantly 
removed (81.4%) in a Korean WWTP (Behera et al., 2011) while it showed minor reduction 
(5%) in a Spanish WWTP (Rosal et al., 2010). Generally, the removal difference among 
different compounds in WWTPs could be ascribed to a number of factors such as 
micropollutant properties and operational conditions.  
The most investigated micropollutants in WWTPs were NSAIDs. Ibuprofen, naproxen 
and ketoprofen exhibited moderate to high removal with average removal efficiency of 
91.4%, 75.5% and 51.7%, respectively. In particular, the eliminations of ibuprofen were 
relatively consistent and commonly higher than 70%. As opposed to other NSAIDs, 
diclofenac experienced fairly inefficient (average 35.8%) and variable removals. The selected 
antibiotics showed low (erythromycin, 30.2%) to moderate removal (sulfamethoxazole, 
64.6%). Lipid regulators and β-blockers were also not efficiently eliminated (37.6%-73.3%) 
in WWTPs. Anticonvulsant carbamazepine seemed to be the most persistent pharmaceutical 
and was averagely reduced by only 32.7%. Among all the reviewed studies, the highset 
removal of carbamazepine was observed by Choi et al. (2008a), reaching 62.3%. As 
mentioned above, caffeine was the most abundant compounds present in municipal 
wastewater. WWTPs proved to be effective in eliminating caffeine with an average removal 
efficiency of 88.7%. In the case of PCPs, relatively high reductions were exhibited, ranging 
between 74.2% (DEET) and 87.5% (galaxolide). As for steroid hormones, relatively stable 
and high removal efficiency was observed, which ranged from 71.9-100%. Two surfactants, 
nonylphenol and octylphenol, showed removals of 77.5% and 84.2%, repectively. 
Contradictory results have been reported for the elimination of nonylphenoel, ranging from 
21.7% (Stasinakis et al., 2008) to 99.0% (Janex-Habibi et al., 2009). The concentrations of 
bisphenol A were commonly considerably lowered (82%) during wastewater treatment. Other 
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selected industrial chemicals also showed removal efficiencies exceeding 80%. Due to the 
fact that pesicides have been typically considered of agricultural rather than of urban origin, 
few studies have been performed at real plant scale and most of reported plants coincide in 
showing insufficient removal of pesticides (Köck-Schulmeyer et al., 2013). The selected 
pesticides, such as atrazine, fluconazole and tebuconazole, were particularly resistant in 
WWTPs.  
It is difficult to draw a firm conclusion on the persistency of each compound, as many 
compounds showed significantly varied removals in different WWTP. However, a simple 
classification of these compounds is presented in Table 6.  




The fate of micropollutants in WWTPs is under the control or influence of ‘internal 
factors’ and ‘external factors’. Internal factors are micropollutant-related, including the 
characteristics of micropollutants (e.g. hydrophobicity, biodegradability, and volatility). In 
general, polar and non-volatile compounds are more likely to escape wastewater treatment 
processes. External factors are WWTP-specific, which are linked to the treatment conditions 
of wastewater treatment processes, the mixture of micropollutants that can act as competitors 
and nature of wastewater (pH and temperature).  
 
3.3.1 Micropollutant‐related	factors	
Sorption of a micropollutant to solids largely depends on the hydrophobicity of the 
compound. The octanol-water partition coefficient (Kow)  is frequently used to predict 
absorption of micropollutants on solids. Rogers (1996) provided a general rule of thumb for 
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applying KOW to the estimation of sorption: logKow < 2.5 indicates low sorption potential, 2.5 
< logKow < 4 indicates medium sorption potential, and logKow > 4 indicates high sorption 
potential.  
Acidity determined by the functional group of a compound can play an important role in 
chemisorption or/and electrostatic adsorption of micropollutants. Schäfer et al. (2011) 
indicated that, at the pH above the acid dissociation constant (pKa), the phenolic hydroxyl 
group of hormones dissociates and the compounds becomes negatively charged, facilitating 
the charge repulsion with the negatively charged membrane. Charge repulsion can also be 
expected to occur between negatively charged compounds and biomass in the activated 
sludge reactors, thereby impeding the removal of micropollutants.  
In activated sludge processes, the solid-water distribution coefficient (Kd) is defined as 
the partition of a compound between the sludge and the water phase. Taking into 
consideration both Kow and pKa, Kd has been proposed as a relative accurate indicator of 
sorption behaviour (Ternes et al., 2004; Joss et al., 2005). For compounds having a Kd of 
below 300 L/kg (log Kd < 2.48), the sorption onto secondary sludge can be considered to be 
insignificant. Additionally, Tadkaew et al. (2011) reported that the studied micropollutants 
with log Kd >3.2 (e.g. estrone and nonylphenol) were easily removed (>85%).   
As biodegradability of micropollutants depends on their bioavailability, the first phase of 
the biodegradation process is the uptake of micropollutants by cell, leading to by chance 
affinity of the compound with the bacterial enzymes (Siegrist et al., 2005). Compound 
structure also plays an important role in determining resistance of a micropollutant to 
biodegradation. The biodegradability of a compound intrinsically relies on the complexity of 
the compound (e.g. monocyclic or polycyclic) and its functional groups (e.g. halogen groups). 
In general, the easily degraded substances include 1) linear compounds with short side chains, 
2) unsaturated aliphatic compounds, and 3) compounds possessing electron donating 
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functional groups. On the other hand, the persistent micropollutants contain 1) compounds 
with long, highly branched side chains, 2) saturated or polycyclic compounds, and 3) 
compounds possessing sulphate, halogen or electron withdrawing functional groups  (Jones et 
al., 2005; Tadkaew et al., 2011). Nevertheless, for some pharmaceutical compounds, there is 
no obvious relationship among chemical structure, functional groups and the removal. For 
example, two structurally similar compounds such as ibuprofen and ketoprofen could show 
different removals, with ibuprofen being eliminated more efficiently (Camacho-Muñoz et al., 
2012).  
Henry's law constant (kH) is commonly used to characterize the volatility of a compound. 
The kH ranging from 10
-2 to 10-3 mol/(m3·Pa) commonly indicates high tendency of 
volatilization (Stenstrom et al., 1989). According to Suárez et al. (2008), volatilization of 
micropollutants is totally negligible for pharmaceuticals and estrogens, nearly negligible for 
fragrance compounds tonalide and galaxolide and very significant for celestolide. 
Volatilisation was found to account for up to 16% of celestolide of the compound (Suárez et 
al., 2010). Furthermore, in activated sludge processes, the volatilization behaviour can be 
intensified due to the additional air supply.  
 
3.3.2 WWTP-specific factors 
Sludge retention time (SRT) controls the size and diversity of a microbial community. 
Enhanced elimination of micropollutants can be achieved if the treatment processes have 
extended SRTs, which facilitate the buildup of slowly growing bacteria, such as nitrifying 
bacteria. In nitrifying conditions, co-metabolism using ammonium monooxygenase enzyme 
is a possible degradation pathway for micropollutants. Nitrifying biomass have been found to 
have positive effects on the removal of a range of micropollutants such as ibuprofen, 
naproxen, fluoxetine, trimethoprim, roxithromycin, erythromycin, galaxolide, tonalide, 
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ethinylestradiol, bisphenol A and nonylphenol. (Suárez et al., 2010; Fernandez-Fontaina et 
al., 2012).  
Clara et al. (2005) suggested that the SRTs allowing nitrogen removal (nitrification and 
denitrification) above 10 days can enhance the elimination of some biodgradable compounds 
(e.g. ibuprofen, bezafibrat, natural estrogens and bisphenol A). In a study, the activated 
sludge treatment with an elevated SRT of 18 days could achieve considerably higher removal 
of beta blockers and psycho-activate drugs in comparison with the same treatment with 
shorter SRT of 0.5 days (Wick et al., 2009). Suárez et al., (2010) identified 10% higher of 
removal efficiency for fluoxetine, citalopram and ethinylestradiol when prolonged SRT was 
applied. Enhanced biodegradation was found for 4-n-nonylphenol and triclosan at SRT of 20 
days (compared with 3 days and 10 days)  (Stasinakis et al., 2010). However, high SRT does 
not necessarily mean better removal performance. Joss et al. (2005) suggested that variation 
of the sludge age between 10 and 60-80 days showed no noticeable effects on removal 
efficiency of the investigated pharmaceuticals. High SRT (20 days) also seemed not to 
appreciably affect the biodegradation of bisphenol A (Stasinakis et al., 2010). Santos et al. 
(2009) indicated that application of low SRTs (1.5-5.1 days) had minor effects on the 
removal of some pharmaceutical compounds (e.g., ibuprofen, diclofenac, naproxen, and 
carbamazepine). 
Hydraulic retention time (HRT) is the amount of time that allows for biodegradation and 
sorption. The micropollutants having slow/intermediate kinetics such as fluoxetine or some 
biotics will experience less effective biodegradation at shorter HRTs or increasing loading 
rates (Fernandez-Fontaina et al., 2012)., Huang et al. (2008) indicated HRT in the range from 
5 to 14 h achieved minor removal of DEHP, while higher HRT increased DEHP 
accumulation in the system and DEHP retention in the waste sludge. 
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Redox condtions may cause the observed differences by having an effect on certain 
wastewater or sludge characteristics as wells as on the biodiversity of the microbial flora 
present (Göbel et al., 2007). Qiang et al. (2013) indicated unfavourable redox conditions 
(anaerobic conditions) could result in inefficient biodegradation of some micropollutants. In 
another study, naproxen, ethinylestradiol , roxithromycin and erythromycin were found only 
considerably eliminated under aerobic condtion and anoxic removal was much less effective 
(Suárez et al., 2010). Zwiener and Frimmel (2003) compared short-term biodegradation of 
clofibric acid, ibuprofen, and diclofenac in oxic and anoxic (denitrification conditions, 
absence of oxygen while presence of nitrate) biofilm reactor. In oxic biofilm reactor, clofibric 
acid and diclofenac were not eliminated, with only 1-4% loss of their initial concentration 
being observed. Ibuprofen was reduced by 64–70%. By contrast, anoxic achieved much 
lower removal of ibuprofen (17-21%) and higher removal of diclofenac (34%-38%) and 
clofibric acid (26-30%). Goel et al. (2003) reported removal of the nonylphenol ethoxylate 
surfactant was higher in the oxic reactors (50 to 70%) compared to the anoxic reactors (30 to 
50%). Similarly, di-(2-ethylhexyl) phthalate were removed by 15%, 19% and 62% in 
anaerobic, anoxic and aerobic reactors (Huang et al., 2008). Anoxic redox conditions were 
not necessarily less favourable enviroments for micropollutant removal. For instance, anoxic 
conditions could lead to improved elimination of iodinated X-ray contrast media, while 
aerobic environments witnessed minor removal (Drewes et al., 2001). Some persistent 
substances, diclofenac, sulfamethoxazole, trimethoprim and carbamazepine showed minor 
removals (<25%) by the either biological treatment with neither nitrifying (oxic) or 
denitrifying bacteria (anoxic) (Suárez et al., 2010). 
Wastewater characteristics, such as pH and temperature, may have effects on 
micropollutant removal. The acidity or alkalinity of an aqueous environment can vary the 
elimination of micropollutants from wastewater by influencing both the physiology of 
21 
 
microorganisms (pH optima of microbial enzyme activities) and the solubility of 
micropollutants present in wastewater (Cirja et al., 2007). Kimura et al. (2010) found that 
modest pH variation had significant effects on the removal of acidic pharmaceuticals 
(clofibric acid, ibuprofen, ketoprofen, naproxen and mefenamic acid) by the biosolids,  which 
was presumably ascribed to activation of enzymes involved or enhancement of affinity 
between the biosolids and pharmaceuticals due to protonation of acidic pharmaceuticals. 
Seasonal variation of temperature may have impact on micropollutant removal in WWTPs. 
Temperature variation can affect biodegradation and partition (sorption and volatilization) of 
micropollutants. To eliminate the seasonal effect, alteration of operation parameters can be 
taken into consideration. For example, a possible strategy to improve EDCs removal in the 
cold temperature is to increase the mixed liquor suspended solids concentration by raising the 
SRT (Nie et al., 2012).  Generally, enhanced micropollutant removal can be achieved at 
warmer temperature due to promoted microbial activities (Nie et al., 2012; Qiang et al., 
2013). Yet, Hai et al. (2011) found that operation at high temperature levels (45 ◦C) could 
lead to lowermicropollutant removal. Some other studies showed micropollutant elimination 




No specific treatment is now available to assure the complete removal of various 
micropollutants due to their diverse properties. Reliable processes that are able to eliminate 
both bulk substances as well as micropollutants are yet to be developed. An overview of the 
current treatment options is present in the following sections to reveal the performance of 





Coagulation-flocculation is used for removing particulate matter, colloids as well as 
some dissolved substances. Table 7 presents some recent literature data regarding the 
removal of the most studied micropollutants from wastewater by coagulation–flocculation 
processes. In general, coagulation-flocculation processes yield ineffective elimination of most 
micropollutants. Matamoros and Salvadó (2013) evaluated the micropollutant removal in a 
coagulation/flocculation – lamellar clarifier for treating secondary effluent. The removals 
ranged from imperceptible elimination to 50%, among which the relatively high removals 
(20-50%) were observed for the compounds with KOW > 4 at pH = 7-8 (e.g. galaxolide, 
tonalide, and octylphenol). Suárez et al. (2009) reported significant reduction (around 80%) 
of musks (e.g. galaxolide and tonalide) during coagulation-flocculation treatment of hospital 
wastewater. The other compounds that showed identifiable elimination were diclofenac (max. 
46%), naproxen (max. 42%) and ibuprofen (max. 23%). Since landfill leachate has been 
considered as an important source of some EDCs, Asakura and Matsuto (2009) pointed out 
that coagulation and sedimentation was not able to remove biphenol A but achieved much 




As a whole, most micropollutants, as shown above, have been reported to be poorly 
removed during coagulation-flocculation processes. Exceptions were some musks, a few 
pharmaceuticals (e.g. diclofenac) and nonylphenol due to their high KOW (4-6). Besides, 
neither coagulant dose nor operation temperature influenced the removal of pesticides 
significantly (Thuy et al., 2008). Despite the minor differences among different types of 
coagulants at different doses, Suárez et al. (2009) reported that the addition of 25 mg/L FeCl3 
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achieved optimal results in most cases. Huerta-Fontela et al. (2011) demonstrated that 
aluminium sulphate was effective in eliminating some hydrophobic pharmaceutical 
compounds. Composition of wastewater can exert either positive or negative effects on 
micropollutant removal during coagulation-flocculation treatment. For example, high fat 
content in water source was reported to improve the removal of hydrophobic compounds 
(Suárez et al., 2009). Dissolved humic acid could also enhance the elimination of some 
pharmaceutical compounds, such as diclofenac, ibuprofen and bezafibrate (Vieno et al., 
2006). On the contrary, the presence of dissolved organic matters (DOM), especially low-
molecular-weight fractions, can possibly inhibit the micropollutant removal due to the 
preferential removal of DOM through coagulation. Negatively charged DOM could react 
with positively charged aluminium hydrolysis species, leading to a less amount of coagulant 
available for elimination of the compounds (Choi et al., 2008b). In addition, the performance 
of coagulation-flocculation processes can be also governed by several operating conditions 
including mixing conditions, pH, alkalinity, temperature as well as the presence of divalent 
cations and concentrations of destabilizing anions (e.g. biocarbonate, chloride, and sulphate) 
(Alexander et al., 2012). 
 
4.2 Activated carbon adsorption 
Adsorption by activated carbons (ACs) is commonly employed for controlling taste and 
ordor in drinking water. This technique also has great potential for treatment of secondary 
effluent and has proved to be more effective in removing micropollutants in comparison with 
coagulation-flocculation process (Choi et al., 2008b). Both powdered activated carbon (PAC) 
and granular activated carbon (GAC) have been widely used in adsorption processes (Table 
8), which can be affected by the properties of both adsorbate (KOW, Pka, molecular size, 
aromacity versus aliphaticity, and presence of specific sunctional groups) and adsorbent 
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(surface area, pore size and texture, surface chemistry, and mineral matter content) (Kovalova 




PAC has been considered as an effective adsorbent for treating persistent/non-
biodegradable organic compounds. An advantage of employing PAC is that it can provide 
fresh carbon continuously or can be used seasonally or occasionally when risk of trace 
organics is present at a high level (Snyder et al., 2007). Kovalova et al. (2013) investigated 
elimination of micropollutants from a MBR-treated hospital effluent using PAC treatment at 
a retention time of two days. With PAC doses of 8, 23 and 43 mg/L and retention time of 2 
days, the PAC reactor achieved efficient elimination for most of the micropollutants 
(pharmaceuticals, metabolites and industrial chemicals). The reduction of total load of 
selected pharmaceuticals and metabolites was around 86%. Batch tests performed by 
Hernández-Leal et al. (2011) also demonstrated marked removal (>94%) of various 
micropollutants (personal care products, bisphenol A and nonylphenol) during PAC treatment 
with initial compound concentrations of 100-1600 µg/L at a dose of 1.25 g/L and a contact 
time of five minutes.  
PAC addition in activated sludge tank or post treatment configurations is a major 
application of PAC in the full-scale municipal WWTPs. A study was carried out to assess the 
efficiency of micropollutants (PPCPs) removal by addition of PAC in different flow schemes 
in municipal wastewater treatment (Boehler et al., 2012). It was found that counter-current 
use of PAC by recycling waste PAC from post-treatment tank to biological treatment tank 
could enhance micropollutant removal by 10 to 50% in comparison with the application 
without recycling. PAC addition in WWTPs was shown to be able to reduce micropollutant 
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levels by more than 80%. The PAC dosage for adequate treatment of secondary effluent with 
dissolved organic carbon (DOC) of 510 mg/L was 1020 mg/L, while a higher amount (30–
40 g/m3 influent) was required to achieve similar results if direct PAC addition was employed 
in biology tank. 
The performance of PAC in eliminating micropollutants depends upon PAC dose and 
contact time, the molecular structure and behavior of the targeted compound, as well as the 
water/wastewater composition (Snyder et al., 2007; Boehler et al., 2012). Either higher dose 
or longer contact time can probably result in greater removal of micropollutants. Westerhoff 
et al. (2005) revealed micropollutant removal was improved with higher PAC dosages (20 
mg/L) and independent of the initial compound concentrations. Water/wastewter composition 
also affects the adsorption of micropollutants. The sorption efficiency of PAC could be 
reduced as the DOC content increases (Boehler et al., 2012). Despite the influence of other 
contaminants in wastewater, the efficacy of applying PAC to wastewater for micropollutant 
removal is comparable with that of ozonation. Thus, PAC addition appears an attractive 




Rossner et al. (2009) suggested that GAC dosage typically applied to taste and odour 
control in drinking water (<10mg/L) was sufficient to provide a 2-log removal for most of 
various compounds in a lake water. Hernández-Leal et al. (2011) evaluated the effectiveness 
of GAC in treating two wastewaters: (1) spiked (0.1-10 µg/L) aerobic effluent in a GAC 
column operated at low flow and (2) aerobic effluent with real concentrations (40 ngL/L to 
7.9 µg/L) of micropollutants in a GAC column. In the first case, removals for all the 
compounds were generally high (>67%), particularly for ethyl-, propyl- and butylparaben, 
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triclosan, caffeine, BP3, PBSA and 4MBC (>90%). In the second case, most compounds 
were also effectively eliminated. Specifically, the removal efficiency ranged from 50% 
(tonalide and nonylphenol) to more than 90% (galaxolide and PBSA).  
A full-scale granular activated carbon plant treating a WWTP effluent was assessed in 
terms of the removal efficiency of steroidal estrogens and pharmaceuticals (Grover et al., 
2011). Considerable removals of steroidal estrogens from sewage effluent were observed 
during the GAC tertiary treatment. By comparison, the reduction of pharmaceutical 
concentrations was more variable. For example, higher removals (84-99%) were observed for 
mebeverine, indomethacine, and diclofenac, while some compounds (e.g. carbamazepine and 
propranolol) displayed much less removals (17-23%). In spite of the efficient treatment of 
sewage effluent, GAC-based removal technology should be carefully operated, as the 
efficiency will decrease over time due to the saturation of adsorption site. 
Similar to PAC, the contact time is a major factor that affects the degree of adsorption. 
Short contact time is likely to lead to significant lowered adsorption efficiency. As the 
elimination of the trace contaminants depends largely upon particle-contaminant interactions, 
the competition for adsorption sites and/or pore blocking (by particle solids) can reduce the 
removal efficiency of activated carbon (Bolong et al., 2009). Thus, GAC tends to perform 
poorly if wastewaters are highly contaminated. Snyder et al. (2007) suggested that a steam-
treated GAC could be employed to overcome the drawbacks of GAC due to its greater 
absorption capacity. Regular regeneration of GAC also seemed of vital importance to 
maintain minimal breakthrough of micropollutants. Furthermore, pore shape/size and 
volumes of activated carbons, carbon type, surface charge of compounds and operation year 




 Broader micropore size distribution of the GAC led to more efficient adsorption of 
compounds with different shapes and sizes; 
 Pore volume was important to adsorption capacity rather than specific area; larger pore 
volume was commonly associated with greater removal efficiency. 
 Negatively charged micropollutants were likely to be poorly adsorbed by the negatively 
charged carbon and well adsorbed by the positively charged carbon; 
 Adsorption capacity reduced with operation year. 
From the aforementioned studies, GAC and PAC appear attractive methods for 
micropollutant removal. In general, efficient removal is potentially achievable when the 
compounds have non-polar characteristics (Kow>2) as well as matching pore size/shape 
requirements (Rossner et al., 2009; Verlicchi et al., 2010b). However, activated carbon 
efficacy might be significantly lowered by presence of natural organic matter which competes 
for binding sides, thereby resulting in blocked pores. Besides, PAC dose, GAC regeneration 
as well as contact time play important roles in efficient removal of micropollutants. 
 
4.3 Ozonation and advanced oxidation processes (AOPs) 
Due to the refractory nature of some micropollutants, conventional physicochemical and 
biological treatments are not able to provide adequate elimination of these compounds. To 
overcome the problem, ozonation and AOPs can be considered. Performance of these 
processes in micropollutant removal is reported in Table 9. Ozonation and AOPs are efficient 
redox technologies which demonstrate some superiority over conventional treatments, such 
as high degradation rates and non-selectivity. Moreover, these processes have disinfecting 
effects, which are essential for reuse applications that involve direct human contact, e.g., 
household reuse applications (Hernández-Leal et al., 2011). Ozone can degrade contaminants 
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directly and indirectly (mainly via formation of stronger and less selective oxidising agent, 
•OH). Some micropollutants are susceptible to both ozone and AOPs (e.g., naproxen and 
carbamazepine), whereas some are only subject to •OH (e.g. atrazine and meprobamate) and 
some are resistant to both forms of oxidation (e.g. TCEP and TCPP) (Gerrity et al., 2011).  




Hernández-Leal et al. (2011) examined the efficiency of ozonation for the removal of a 
wide range of micropollutants (UV-filter, fragrance, biocide and surfactant) from biologically 
treated grey water. In general, all the compounds were significantly removed (>79%) from 
the biologically treated effluent at an applied ozone dose of 15 mg/L. In another study, lower 
ozone dose of 5 mg/L also showed high removal efficiency for most of the targeted 
micropollutants (Sui et al., 2010). The concentrations of carbamazepine, diclofenac, 
indomethacin, sulpiride and trimethoprim were considerably reduced by more than 95%. The 
reductions of DEET and metoprolol were modest. By contrast, bezafibrate was very resistant 
to ozonation and was removed by only 14%. 
A study conducted by Gerrity et al. (2011) focused on the application of O3/H2O2 for 
removing a suite of micropollutants (PPCPs and steroid hormones) during water reclamation. 
The process showed considerable removal efficiency (>90%) for almost all of the target 
contaminants, except TCEP (13%), TCPP (26%), atrazine (69%), meprobamate (80%), and 
ibuprofen (83%). They indicated that micropollutants which exhibited the highest levels of 
oxidation were characterized by high ozone and •OH rate constants associated with their 
electron-rich moieties (e.g., phenols, anilines, olefins and activated aromatic). Although the 
formation of •OH was enhanced under alkaline conditions, Zhang et al. (2012) reported lower 
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pH was beneficial for EDCs removal by ozone when treating synthetic secondary effluent. 
This is because ozone was less reactive to the inorganic and organic matters (non-target 
compounds) in the synthetic secondary effluent as compared to •OH (generated at high pH) 
and a greater amount of O3 could thereby be preserved for the reactions with target 
compounds. Furthermore, in spite of the fact that suspended sludge particles could lead to 
higher O3 consumption, which might reduce the efficiency of ozonation for micropollutant 
removal, this effect was not significant and had only a minor impact on ozonation as well as 
oxidation by •OH at low O3 dosages (Huber et al., 2005; Hernández-Leal et al., 2011). 
Kim et al. (2009b) examined the effectiveness of UV (wave length: 254mm)-based 
processes (UV and UV/H2O2) for the elimination of 41 pharmaceutical compounds. UV alone 
could significantly remove (>90%) only a few compounds (e.g. ketoprofen, diclofenac and 
antipyrine) while ineffective removals (24%-34%) were observed for macrolides. By 
contrast, with the addition of H2O2 (7.8 mg/L), the process considerably improved its efficacy 
and removal efficiency increased up to 90% for 39 out of 41 compounds. Treatment of 32 
selected micropollutants (pharmaceuticals, corrosion inhibitors and biocides/pesticides) in an 
effluent coming from a municipal activated sludge WWTP was also investigated using UV 
(wavelength: 254 nm), UV/H2O2, Fenton (Fe
2+,3+/H2O2) and photo-Fenton (Fe
2+,3+/H2O2/UV 
and Fe2+,3+/H2O2/simulated sunlight) (De la Cruz et al., 2012). The process with only UV 
irradiation yielded a global degradation of 46% for the micropollutants after 10min. Four 
compounds (diclofenac, ketoprofen, memfenamic acid and diuron) were completed removed 
during the process. In contrast, the concentrations of gabapentin, trimethoprim, metformin, 
primidone, azithromycin and clarithromycin were unaltered or only slightly reduced (<10%). 
Comparing with UV treatment alone, UV and H2O2 (50 mg/L) exhibited elevated 
transformation (a total degradation of 81%) of the micropollutants. After 30 min of UV/H2O2, 
the transformation increased further up to 97%. Fenton process (5 mg/L Fe2+, 3+/ 50 mg/L 
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H2O2) achieved 31% degradation. It was able to completely eliminate only one of the 
micropollutants, norfloxacin, after 30 min, and the concentrations of ten compounds were 
reduced by less than 15%. When UV was applied to the process (under the same conditions 
mentioned above), significantly increased global degradation (97%) was observed. For the 
photo-Fenton process, either increased H2O2 dosage or extended reaction time was found to 
have positive impact on the global degradation. Fenton/UV254 (100% degradation after 90 
min) displayed much higher degradation efficiency compared with Fenton/sunlight (47% 
degradation after 90 min). In addition, the presence of dissolved organic matter in the 
wastewater seemed to enhance the micropollutant removal during all the processes. In 
another study, Klamerth et al. (2010) reported much higher efficiency of photo-Fenton with 
solar light for treatment of 52 micropollutants (PPCPs and pesticides) in a WWTP effluent. 
The process was able to degraded 48 compounds below their limit of detection. 
 
4.4 Membrane processes 
Table 10 presents some recent research data concerning the effectiveness of membrane 
technology in eliminating micropollutants. The retention of micropollutants in membrane 
processes can generally achieved by size exclusion, adsorption onto membrane, and charge 
repulsion. These removal mechanisms are largely dependent on a number of factors, such as 
membrane process type, membrane characteristics, operating conditions, specific 
micropollutant characteristics and membrane fouling (Schäfer et al., 2011).  
Table 10 
 
Although Microfiltration (MF) and Ultrafiltration (UF) are proved processes to 
efficiently eliminate turbidity, micropollutants are generally poorly removed during UF and 
MF, as the membrane pore sizes are much larger than the molecular sizes of micropollutants. 
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However, micropollutants can be removed via adsorption on to membrane polymers, as well 
as  interaction with natural organic matter (NOM) in wastewater. Jermann et al. (2009) 
examined the fate of ibuprofen and estradiol during an UF process and the effects of fouling 
by NOM. Without NOM, UF with hydrophilic membrane showed insignificant removal for 
ibuprofen and low (8%) removal for estradiol, while hydrophobic membrane retain much 
larger amount of estradiol (up to 80%) and ibuprofen (up to 25%). The higher retention of 
estradiol was due to the higher Carbon-Water Partitioning Coefficient (Koc) value of the 
compound. As for the effect of NOM, NOM substances of high molecular weight such as 
alginate and Aldrich HA showed a greater effect than the lower molecular weight Nordic 
aquatic humic acid on enhancing micropollutant removal. Due to the low removal efficiency, 
MF or UF alone is not feasible for micropollutant removal. Hence, the combination of MF or 
UF with other processes (e.g. NF or RO) is essential for enhanced elimination of different 
micropollutants. Garcia et al. (2013) combined MF with RO to remove micropollutants for 
municipal wastewater reuse. MF was found to be able to reduce the concentrations of some 
compounds, such as bis-(2-ethylhexyl) phthalate, by more than 50%. With the incorporation 
of RO, the removal efficiency was significantly improved, ranging from 65% to 90% for 
most micropollutants (except ibuprofen and nonylphenol). Similarly, a tertiary MF/RO 
treatment process exhibited very efficient retention (>95%) of most of the studied PPCPs, 
except mefenamic acid and caffeine (Sui et al., 2010).  
In comparison with MF and UF, nanaofiltration (NF) and reverse osmosis (RO) have 
much “tigher” structures. NF and RO are widely used in water reuse industry due to their 
high contaminant removal efficiency. However, NF and RO membranes are still somewhat 
permeable to some relatively small micropollutants (Steinle-Darling et al., 2010).  
Röhricht et al. (2009) investigated two different types of submerged NF flat sheet 
modules for the removal of pharmaceuticals from WWTP effluent. Naproxen and diclofenac 
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(60%) were retained to a greater extent compared with carbamazepine (slight removal). At 
pH 7 and 8, naproxen and diclofenac (with pKa values of 4.2 and 4.15, repectively) were 
deprotonated, while carbamazepine (pKa=13.9) was not. Hence, naproxen and diclofenac 
could be rejected by the negatively charged membrane surface, whereas carbamazepine could 
not be removed. This was in accordance with the viewpoint indicated by Schäfer et al. (2003) 
and Nghiem et al. (2005): the speciation of pharmaceuticals may result in a significant 
change in rejection as a function of pH, with much greater retention occurring for ionized, 
negatively charged pharmaceuticals. For uncharged pharmaceuticals, intrinsic 
physicochemical properties of the pharmaceutical molecules play a role in their retention. 
Apart from electrostatic repulsion, adsorption can serve as the overriding removal mechanism 
in some cases. This was demonstrated in a study evaluating the removal of a variety of 
EDC/PPCPs using UF or NF (Yoon et al., 2006). For more polar compounds, the NF 
membrane (44–93% removals except naproxen of no rejection) was more efficient than the 
UF membrane with typical removals of less than 40% except a few compounds (triclosan, 
87%; oxybenzone, 77%; progesterone, 56%). By contrast, for the less polar compounds, 
many permeate EDC/PPCP concentrations (14 out of the 25 compounds) were below 
detection, suggesting high removal efficience by both NF and UF membranes except for a 
few compounds (α- and β-BHC, fluoranthene, hydrocodone, metolachlor, and musk ketone). 
Better performance was also observed for NF. 
RO generally shows great potential to partially or significantly remove micropollutants. 
Sahar et al. (2011) applied RO after CAS-UF and MBR processes and assessed its efficiency 
in eliminating micropollutants. The two processes, CAS-UF/RO and MBR/RO, showed 
relatively similar and high elimination efficiencies: >99% for macrolides, pharmaceuticals, 
cholesterol and BPA, 95% for diclofenac, 97% for SMX, and >93% for both SMZ and TMP. 
Despite the highly effective RO treatment, 28-223 ng/L residuals of ibuprofen, diclofenac, 
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salicylic acid, cholesterol, and BPA were detected in the permeates from both units. This 
elucidated that RO was not an absolute barrier for micropollutants. Yangali-Quintanilla et al. 
(2011) compared the various micropollutants (pharmaceuticals, pesticides, endocrine 
disruptors and others) removal by NF and RO. The elimination efficiency of NF membranes 
was very close to that achieved by RO membranes. The average retention efficiency by tight 
NF was 82% for neutral contaminants and 97% for ionic contaminants, while RO was able to 
achieve 85% removal of neutral contaminants and 99% removal of ionic contaminants. 
 
4.5 Membrane bioreactor 
Membrane bioreactor (MBR) process combine activated sludge biological treatment and 
membrane filtration (MF and UF). MBRs possess the following advantages over 
conventional wastewater treatment in the following aspects (Ngo et al, 2012) such as high 
effluent quality. excellent microbial separation ability, absolute control of SRTs and HRTs, 
high biomass content and less sludge bulking problem, low-rate sludge production, small 
footprint and limited space requirement, and possibilities for a flexible and phased extension 
of existing wastewater treatment plants (WWTPs). 
MBRs are able to effectively remove a wide spectrum of micropollutants including 
compounds that are resistant to activate sludge processes (Radjenovic et al., 2009). This is 
because 1) They are able to retain sludge to which many compounds are adhered; 2) The 
membrane surface can also intercept the compounds; 3) The longer SRT in MBRs may 
promote microbial degradation of the compounds (Spring et al., 2007). Table 11 summarizes 
some recent studies involving MBR processes. The removal of micropollutants in MBR can 
be affected by a number of factors, such as sludge age and concentration, existence of anoxic 
and anaerobic compartments, composition of the wastewater, operating temperatures, pH and 





Trinh et al. (2012) investigated the micropollutant removal efficiency of a full-scale 
MBR. High elimination (>90%) was observed for most of the micropollutants. Nevertheless, 
some compounds were incompletely removed (24-68%), including amitriptyline, 
carbamazepine, diazeoam, diclofenac, fluoxetine, gemfibrozil, omeprazole, 
sulphamethoxazole and trimethoprim. Hence, these compounds were considered as potential 
indicators for evaluating the micropollutant removal using MBR processes. Generally, 
hospitals are the major source of many pharmaceuticals released into the environement 
(Verlicchi et al., 2010a). A pilot-scale MBR was employed for on-site treatment of hospital 
effluent (Kovalova et al., 2102). In this study, they elucidated that the concentrations of 
investigated compounds in the hospital wastewater were considerably different from those in 
municipal wastewater. For instance, average 32 μg/L of the antibiotic ciprofloxacin and up to 
2600 μg/L of iodinated X-ray contrast media were detected in the hospital wastewater, which 
was around 70-time higher than those observed in the municipal wastewater. In addition, 
higher concentrations of antibiotics and disinfectants due to large amounts of usage in 
hospitals could lead to bacterial inhibition during the on-site treatment. The overall 
recucation of all pharmaceuticals and metabolites was only 22%, as a large fraction (80%) of 
the feed was persistent iodinated contrast media. However, if the iodinated contrast media 
were not taken into account, the reduction would be up to 90%. Full-scale MBR studies for 
hospital wastewater treatment were also investigated by Beiber et al. (2011), which suggested 
that separation of rainwater collection and water streams with low pharmaceutical 
concentrations, and maintenance of sludge age > 100 days should be considered in the design 
of MBR for hospital wastewater. 
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Both being cost effective technologies in wastewater treatment, MBR processes and 
conventional activated sludge (CAS) processes have been frequently compared in terms of 
their performance in micropollutant removal. Radjenovic et al. (2007) compared the removal 
of several pharmaceutical products in a laboratory scale MBR and a CAS process. Both 
systems were effective in removing some compounds (e.g., naproxen, ibuprofen, 
acetaminophen, hydrochlorothiazide, and paroxetine). However, the results presented that 
pharmaceuticals showed greater and steadier elimination during MBR process (>80% in most 
cases). Another comparative investigation of MBR and CAS process was performed by Chen 
et al. (2008). Similarly, MBR was slightly more efficient in micropollutant removal. The 
efficiency of elimination in the MBR appeared stable regardless of changes in sludge loading 
and HRT. 
Biological treatment combined with membrane filtration (MF or UF) are also employed 
for treating wastewater. Sahar et al. (2011) compared the removals of several macrolide, 
sulphonamide and trimethoprim antibiotics from raw sewage using a full-scale CAS system 
coupled with a subsequent UF filtration (CAS-UF) and a pilot scale MBR. Antibiotics 
removal in the MBR system was generally higher than that in the CAS-UF system. The 
elimination of Trimethoprim, sulfamethoxazole and erythromycin was 99%, 70%, 61% in the 
MBR system, and 45%, 52% and 71% in the CAS-UF system, respectively. It was assumed 
that antibiotics removal in both systems was due either to sorption to biomass (rather than 
biological transformation) or to enmeshment in the membrane biofilm (as the pore size of UF 
is significantly larger than the antibiotic molecules). 
Recently, membranes in conjunction with anaerobic reactors have been gaining 
popularity due to their intrinsic advantages over aerobic systems, such as low sludge 
production, net energy generation and a fully enclosed environment (Hu and Stuckey, 2006). 
The applications of anaerobic MBRs for micropollutant removal have been investigated in 
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some recent studies (Xu et al., 2008; Abargues et al., 2012). A pilot-scale submerged 
anaerobic MBR (SAnMBR), a conventional activated sludge (CAS) unit and a pilot-scale 
aerobic MBR were evaluated for removing some alkylphenols (APs) and hormones 
(Abargues et al., 2012). The observed concentrations of APs in the SAnMBR effluent were 
consistently at significantly higher levels than those in the permeates from other units, 
indicating the ineffective removal of APs by SAnMBR.  
During MBR processes, several operational parameters (e.g. SRT, HRT and 
temperature) can influence the reduction of micropollutants. In general, MBRs have high 
SRTs, thus diverse microorganisms, including some slow growing bacterial, can reside in the 
reactors. When biomass is rich in nitrifying bacterial, higher biodegradation efficiency for 
certain micropollutants can be achieved (Roh et al., 2009). De Gusseme et al. (2009) reported 
a high elimination (99%) of 17α-ethinylestradiol (at initial concentration of 83 ng/L1) when a 
nitrifier enrichment culture was applied in a MBR. The degradation of micropollutants by 
nitrifying bacteria has also been evaluated in other types of systems (e.g., activated sludge 
and fixed bed reactor) (Batt et al., 2006; Forrez et al., 2009; Zhou and Oleszkiewicz, 2010). A 
general conclusion drawn from these studies is that nitrifying conditions have positive effects 
on micropollutant removal. Temperature variability has been linked to decrease in bulk water 
quality parameters and unreliability of system, as microbial growth and activity as well as 
solubility and other physicochemical properties of organics are significantly affected by 
temperature (Hai et al., 2011). Effects of temperature variation were explored in a lab-scale 
MBR treating wastewater containing selected micropollutants (Hai et al., 2011). Both 
hydrophobic compounds (log D > 3.2) and less hydrophobic compounds (log D < 3.2) 
showed reduced elimination at 45C, which was ascribed to disrupted metabolic activity 
typically linked to such elevated temperature. The removal of hydrophobic compounds was 
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unaffected in the temperature range of 10–35C, while a relatively more obvious variation 
was found in the removals of less hydrophobic compounds. 
 
4.6 Attached growth treatment processes 
Attached growth technology is a promising alternative to activate sludge processes for 
wastewater treatment which involves attached growth on inert carriers either fixed or 
mobilised in suspension of the reactor. The attached growth processes offer the following 
advantages over activated sludge processes in wastewater treatment (Guo et al., 2012): 
 They have better oxygen transfer, high nitrification rate and higher biomass 
concentrations;  
 They are more effective in organic removal, and can apply for high organic loading 
rates at relatively shorter HRT; 
 They allow the development of microorganisms with relatively low specific growth 
rates (e.g., methanogens); 
 They are less subject to variable or intermittent loadings; 
 They are suitable for small reactor size, with space requirement being considerably 
lower than that for AS; and  
 For fixed-bed biofilm processes such as trickling filters and rotating biological 
contactors (RBCs), the operational costs are lower than that for AS. 
The attached growth systems can be grouped into two major groups: fixed bed 
bioreactors (e.g. biofiltration) and moving bed bioreactors. Table 12 presents the 





Biofiltration seems a compelling biological technique for micropollutant removal 
(Reungoat et al., 2011). Commonly used systems in water and wastewater treatment include 
trickling filter, sand filtration and biological activated carbon (BAC). A BAC filter is 
typically composed of a fixed bed of GAC serving as the carrier for bacterial adhesion and 
growth. Reungoat et al. (2011) evaluated and compared the performance of biofilters with 
two media, activated carbon and sand, during long-term operation. The results demonstrated 
that BAC had a great potential for PPCPs (e.g. diclofenac, carbamazepine, sulfamethoxazole 
and gemfibrozil) removal (> 90%) and reduction of the potential risk of environmental and/or 
human health impact. On the other hand, sand filters could only achieve limited elimination 
for PPCPs. Dissolved oxygen was the main factor affecting the performance of BAC filters, 
while empty-bed contact time (from 30 min to 120 min) did not result in considerable 
variation in the removals of compounds. In addition, long-term observation indicated that the 
main mechanism for organic matter and PPCP removal in biofiltration was biodegradation 
rather than adsorption. Another biofilter, namely sequencing batch biofilter granular reactor 
(SBBGR), was investigated by Balest et al. (2008) for removing several selected EDCs. The 
results showed that SBBGR achieved much higher removal efficiency for EDCs removal than 
the  conventional activated sludge process in a municipal WWTP. The removal effiencies for 
bisphenol A, estrone, estradiol and 4-tert-octylphenol were 91.8%, 62.2%, 68% and 77.9% 
for the demonstrative SBBGR system and 71.3%, 56.4% 36.3% and 64.6% for the 
conventional activated sludge process of the municipal WWTP, respectively. The excellent 
performance of the SBBGR was attributed to the very high sludge age (about 160 d). Due to 
the excellent performance, biofiltration was suggested as an efficient treatment method that 
could be employed in advanced treatment processes for reducing the impact of the effluent 
discharge into the environment and/or providing water of higher quality for reuse. 
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The biological removal of 17α-ethinylestradiol in an aerated submerged fixed bed 
bioreactor was evaluated with or without ammonium starvation (Forrez et al., 2009). 
Excellent removal (96%) was obtained at a volumetric loading rate of 11 µg/Ld of 17α-
ethinylestradiol, slightly lower elimination rates (81 and 74% respectively) was reported 
when increasing the loading rate up to 40 and 143 µg/Ld of 17α-ethinylestradiol. The authors 
suggested that implementation of retro-fitting treatment systems, either by employing a post-
treatment reactor containing separately grown ammonia-oxidizing bacterial (AOB) or by 
continuously seeding the WWTP effluent with AOB grown in a dedicated reactor has great 
potential for the removal of some micropollutants (Forrez et al., 2009). In another study using 
a fixed film activated sludge (IFAS) to treat effluent estrogenic activities, Kim et al. (2009a) 
found the effluent estrogenic activities in the IFAS system were 70% lower than those in the 
control train (conventional activated sludge system), which suggested a high estrogen 
removal by IFAS. 
Falås et al. (2012) conducted a set of batch experiments to evaluate the effectiveness of a 
hybrid moving bed biofilm activated sludge process for the removal of various 
micropollutants. It was indicated that the presence of carriers could enhance the overall 
biological elimination of some compounds. For example, diclofenac, clofibric acid and 
mefenamic acid were not eliminated in the activated sludge reactors, while the carrier 
reactors showed more obvious and rapid removals (at least 60% after 24 h) of the three 
compounds. In another study, a moving bed biofilm system was investigated in terms of the 
removal efficiency for bisphenol A, oseltamivir and atrazine from wastewater using carriers 
made from existing bioplastic-based products (Accinelli et al., 2012). During the experiments 
with control wastewater samples, mineralization rates for bisphenol A, oseltamivir and 
atrazine were relatively low, accounting for only 18%, 7% and 3.5% of the initial 
concentrations, respectively. By contrast, the addition of incubated carriers enhanced the 
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removals of bisphenol A, oseltamivir and atrazine by 34%, 49% and 66%, respectively. Li et 
al. (2011) focused their study on simultaneous PAC adsorption within a MBR. During the 
treatment, PAC could not only act as an adsorbent but also provided support for biomass 
growth. With a high PAC dosage of 1.0 g/L, enhanced elimination of sulfamethoxazole and 
carbamazepine was observed in the PAC-amended MBR system (82% and 92% respectively) 
in comparison with the MBR system alone (both 64%).  
As a whole, although attached growth systems have not been applied broadly and 
specifically to for micropollutant removal , the results from some recent bench-scale or pilot 
scale studies showed that attached growth treatment processes are promising methods for 
reducing discharges of micropollutants. By addition of packing/moving carriers, increased 
microbial community can be maintained in the system, which facilitates the growth of slow-
growing microorganisms for micropollutant removal (Serrano et al., 2011). Therefore, 
micropollutant removal by attached growth processes is a strategy showing possibility of 
excellence and likely to draw more attention in the future research. 
 
5. Assessment of micropollutant removal from municipal wastewater and 
recommendation for future research 
Micropollutants have been frequently detected in wastewater as well as important 
drinking water sources, such as rivers, lakes and groundwater. The evaluation of 
micropollutants from municipal sewage should cover a series of issues from sources to end 
uses, including selection of micropollutants with high occurrence and ecotoxicological 
relevance, determination of possible sources, investigation on their occurrence and fate in 
WWTPs and receiving waters, and estimation of their (eco)-toxicological impacts on aquatic 
systems and humans. 
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The major types of wastewater media that convey micropollutants to aquatic systems via  
WWTPs consist of domestic wastewater, hospital effluents, industrial wastewater and  
stormwater runoff, rural runoff and manure. Intense efforts have been taken to investigate  
domestic wastewater, while less focus has been put on other types of wastewaters which may  
also have significant micropollutant loads. For example, hospitals are a considerable source  
of various pharmaceuticals, including compounds generated from diagnostic, laboratory and  
research activities as well as pharmaceutical excretion by patients (Verlicchi et al., 2010b).   
Industrial practices (e.g. production of various commodities) can probably lead to a  
remarkable discharge of micropollutants, especially EDCs, due to the use or/and formation of  
the compounds during the production processes.  The assessment of the significance for  
different sources can be based on the compilation of literature data (Pal et al., 2010). Scale of  
consumption or production (e.g. annual per capita consumption) of commodities containing  
micropollutants can also be used as an indicator for micropollutants emission. Zhang et al.  
(2008) suggested that the worldwide annual per capita consumption of drugs is 15 g and  
developed countries contribute three to ten times higher (50-150 g).   
Since WWTPs are not able to provide a complete barrier for micropollutant removal,  
establishing optimal removal strategies for micropollutants remains a challenge to  
environmental engineers in order to minimize their adverse effects on the environment.  
Conventional treatment processes have been reported to have inadequate removals of many  
micropollutants. Several potential options are available for improving the elimination of  
micropollutants, including source controls (e.g. application of micropollutant-free products,  
source separation, pretreatment of hospital and industrial effluents, etc.), reassessment and  
optimization of current treatment processes, and end-of-pipe upgrading of WWTPs. As  
mentioned above, the removal of highly persistent/non-biodegradable/polar micropollutants  
is commonly low and independent of operating parameters during biological treatment  
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processes, thereby exceeding the capacity of current treatment processes. Hence, tertiary (e.g. 
post ozonation, sand filtration, and membrance filtration) or combined treatment processes 
should be taken into consideration to ensure successful treatment of the variety of 
micropollutants. Table 13 compares the micropollutant removal efficiency of three types of 
WWTPs, namely low-cost, conventional and advanced WWTPs. Low-cost treatment 
processes, such as trickling filter beds, lagooning and constructed wetland, are normally used 
for decentralized wastewater treatment for small communities and in a few cases applied in 
centralized WWTPs for large communities. As can be seen in Table 13, WWTPs with low-
cost treatment processes exhibit comparatively low efficiency, while WWTPs with tertiary 
treatments show more efficient and consistent removal of the compounds. Camacho-Muñoz 
et al. (2012) concluded that most of the pharmaceutical compounds they studied were slightly 
better removed in conventional treatment processes, which could be attributed to the better 
aeration condition that led to more effective aerobic degradation. Meanwhile, the lowest 
removal efficiency for some compounds (carbamazepine, propranolol and estriol) occurred in 
lagooning compared with other conventional treatments and could be ascribed to the low 
organic content of wastewater as well as the low amount of solids and poor aeration. 
Nevertheless, the differences between the mean removal rates in conventional (64%) and 
low-cost (55%) WWTPs were not significant. RO as a tertiary treatment showed 100% 
removal for COD and selected EDCs, but the elevated energy consumption is a consistent 
disadvantage (Balabanič et al., 2012). Salgado et al (2012) assessed a full-scale WWTP 
employing UV as the post-treatment for PPCP removal. They evaluated the relevance of each 
removal mechanism for the overall PPCP removal and indicated that the removal fractions 
from biodegradation, sorption and UV are 45%, 33% and 22% respectively. Although UV 






Table 14 summarizes the advantages and disadvantages of different treatment techniques 
reviewed. The provided information is based on the recent literature and may be helpful to 
select suitable techniques for micropollutants treatment. However, the table only gives the 
qualitative assessment of these techniques. Comprehensive quantitative assessment is needed 
in future research to better compare different techniques from both economic and technical 




Understanding and predicting the fate of micropollutants in WWTPs is helpful in 
identifying the improvement potential for current treatment configurations. To date, 
enormous efforts by many researchers have been put into developing accurate and succinct 
models for micropollutants prediction. Precise models for micropollutant fate are not easy to 
establish. Modellers should take into account numerous aspects, including possible removal 
pathways and factors that affect the removal. Pomiès et al. (2013) reviewed different models 
from the perspective of removal pathways. Sorption and volatilisation can be characterized 
by partition coefficient Kd and Henry’s law constant, both of which can be determined 
experimentally. Biodegradation modelling is a more complicated process due to the 
involvement of microorganisms. Two issues have been addressed for the biodegradation of 
micropollutants. First issue is the lack of conformity in determining biodegradation sites 
(only in aqueous phase, only in solid phase or in both phases). The other is the incorporation 
of parent compounds and by-products as well as co-metabolism in the models. 
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The discharge of micropollutants can contribute to water pollution due to their 
potentially ecotoxicological impacts on aquatic organisms. Furthermore, human exposure to 
micropollutants is also harmful and can occur via various routes. According to Figure 1, 
micropollutants can return to humans via drinking water. Other pathways back to humans 
include food chain and wastewater reuse for household purposes. Given their adverse effects, 
effective monitoring strategies and risk assessment should be considered as important 
components for micropollutants control. Nevertheless, monitoring programmes for 
micropollutants are far from universal and have only been carried out in sizable rivers, such 
as Rhine (Sacher et al., 2008) and Han River (Choi et al., 2008a), as those programs are time 
consuming and costly (Alder et al., 2010). Therefore, the establishment of estimation tools 
for the concentrations and mass flows of micropollutants in surface waters is of vital 
importance. Generally, the estimation should be based on the various sources, 
use/consumption of compounds and their fate in WWTPs as well as receiving waters. 
Coetsier et al. (2009) indicated predicted environmental concentrations (PECs) offers the 
possibility to predict pharmaceutical occurrence in surface water. Although the PEC values 
seemed to be able to properly estimate WWTP wastewater effluents, they are subjected to 
uncertainties because the differences between predicted and measured values can become 
significant when applied to local areas with consumption levels being considerably different 
from assumed average levels. 
After discharged into surface waters, micropollutants experience various processes, 
including dilution and attenuation (biodgradation, sorption, volatilization and photolysis). A 
comprehensive understanding and modelling of micropollutants fate in surface waters is 
essential for effectively predicting micropollutants’ impacts on the receiving environment. 
Although integrated urban water system (IUWS) modelling is usually used as a tool for 
evaluating the quality of the surface water receiving the municipal WWTP discharge 
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combining sewer overflows and stormwater drainage systems, many micropollutants tend to 
distribute to more than one environmental compartment (air, water, sediment, soil, 
groundwater, etc.). Hence, a multimedia fate and transport model (MFTM) was proposed by 




Enormous research effort has been directed toward the assessment of occurrence of 
micropollutants in the aquatic environment. In particular cases, the occurrence levels of some 
micropollutants in surface waters were much higher than their PNECs, which revealed an 
environmental concern. WWTP effluent has been considered as the primary source of many 
micropollutants in aquatic systems. Given their diverse properties (e.g., hydrophobicity and 
biodegradability) and low concentrations, micropollutant removal in current WWTPs is 
commonly incomplete and variable, ranging from 18.8% to 91.1% for some frequently 
reported compounds. Hence, optimization of wastewater treatment, in order to create an 
absolute barrier to micropollutants emission, remains a task of high priority. Biological 
treatment is commonly unable to remove polar persistent micropollutants. However, its 
efficacy can be improved under favourable conditions (e.g., extended SRT and HRT, warm 
temperature, and fine tuning redox conditions). Although advanced treatment technologies, 
such as adsorption processes, AOPs and membrane processes, have been demonstrated to be 
promising alternatives for micropollutant removal, there are two issues associated with the 
applications of advanced treatments: high operation costs and formation of byproducts and 
concentrated residues. Moreover, to effectively predict the impact of micropollutants on the 
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Sources of micropollutants in the aquatic environment 
Category Important subclasses Major sources 
Distinct Nonexclusive 
Pharmaceuticals NSAIDsa, lipid regulator, 
anticonvulsants, antibiotics, β-
blockers and stimulants 
 Domestic wastewater (from excretion) 
 Hospital effluents 
 Run-off from CAFOsb and aquaculture 
Sources that are not exclusive to 
individual categories include: 
 Industrial wastewater (from 
product manufacturing discharges) 
 Landfill leachate (from improper 





Fragrances, disinfectants, UV filters, 
and     insect repellents 
 Domestic wastewater (from bathing, 
shaving, spraying, swimming and etc.) 
Steroid 
hormones              
Estrogens  Domestic wastewater (from excretion) 
 Run-off from CAFOs and aquaculture 
Surfactants Non-ionic surfactants  Domestic wastewater (from bathing, 
laundry, dishwashing and etc.) 




Plasticizers, fire retardants  Domestic wastewater (by leaching out 
of the material) 
Pesticides Organochlorine insecticides, 
organophosphorus insecticides, 
herbicides and fungicides 
 Domestic wastewater (from improper 
cleaning, run-off from gardens, lawns 
and roadways and etc.) 
 Agricultural runoff 
a NSAIDs: non-steroidal anti-inflammatory drugs; bCAFOs: concentrated animal feeding operations. 
Table 2 
The concentration and removal of micropollutants in WWPTs of different countries   
Categories Selected compounds Sampling sites  Influent (µg/L) Effluent (µg/L) Removal (%)c References
d 
Pharmaceutical       
Analgesic and 
antiinflammatory 
      
       
 Acetaminophen Spain, Korea, WBa 1.57-56.94 0-0.03 98.7-100 2, 5, 8, 24, 25e
 Diclofenac EU-widea, Greece, Korea, 
Sweden, Switzerland, UK, 
WB 
<0.001-4.2 <0.001-0.69 -105-81.4 2, 8, 11, 14f, 20, 
21, 24, 25, 27, 28 
 Ibuprofen China, EU-widea, Greece, 
Korea, Sweden, UK, US, WB 
<0.004-603 NDc-55 72-100 2, 8, 11, 14, 19, 
21, 24, 25, 26, 28 
 Ketoprofen China, EU-widea, Korea, 
Spain, UK, WB 
<0.004-8.56 <0.003-3.92 11.2-100 2, 8, 11, 14, 19, 
25, 27 
 Mefenamic acid EU-wide, Korea, Spain, UK <0.017-1.27 <0.005-0.39 -387.5-70.2 2, 8, 11, 24 
 Naproxen Greece, Korea, Spain, 
Sweden, UK, WB 
<0.002-52.90 <0.002-5.09 43-95.7 2, 8, 11, 19, 21, 
24, 25, 28 
 Salicylic acid Greece,  Spain, UK  0.576-63.7 ND-0.50 92.8-100 8, 11, 21 
Anticonvulsant       
 Carbamazepine China, EU-wide , Greece, 
Korea, Spain, UK, WB 
<0.04-3.78 <0.005-4.60 -114.2-62.3 2, 5, 11, 14, 19, 
24, 25, 27 
Lipid regulator       
 Bezafibrate EU-wide, Spain, Korea, UK, 
WB 
0.05-1.39 0.03-0.67 9.1-70.5 2, 8, 11, 14, 24, 
25 
 Clofibric acid China, EU-wide, Greece, , 
Korea, Spain, Sweden, UK, 
WB 
 0-0.74 0-0.33 9.9-93.6 2, 11, 14, 21, 24, 
25, 28 
 Gemfibrozil EU-wide, Greece, Korea, 
Spain, WB 
0.10-17.06 <0.0025-5.24 -133.3-92.3 2, 8, 14, 21, 24, 
25 
Antibiotic       
 Erythromycin China, Spain, UK, WB 0.14-10.03 0.02-2.84 -100-82.5 8, 11, 24, 25, 27 
 Sulfamethoxazole EU-wide, France, Korea, 
Spain, Sweden, Switzerland, 
UK, WB 
<0.003-0.98 <0.003-1.15 4-91.7 2, 5, 8, 11, 14, 15, 
20, 24, 25 
 Trimethoprim China, EU-wide, Korea, 
Spain, UK  
0.06-6.80 <0.01-3.05 -80->88.1 2, 5, 8, 11, 14, 24, 
25, 27 
β-blocker       
 Atenolol Korea, Spain, Switzerland, 
UK,WB 
0.1-33.106 0.13-7.60 -33.3-83.0 1, 2, 11, 24, 25 
 Metoprolol China,  Korea, Spain, 
Switzerland,  UK 
0.002-1.52 0.003-0.25 3-83.5 1, 2, 8, 11, 24 
 
Nervous stimulant       
 Caffeine Spain, UK, Korea, China, EU-
wide, Greek 
0.22-209 0-43.50 44-99.8 2, 5, 14,19, 21, 
24, 26, 27 
PCPa       
Musk fragrance       
 Galaxolide Spain, WB 0.03-24.97 <0.06-2.77 87.8 24, 25 
 Tonalide Spain, WB <0.05 –1.93 <0.05-0.32 84.7 24, 25 
Disinfectant       
 Triclosan Spain, UK, US,  Greece, 
Korea , France, EU-wide 
0.03-23.90 0.01-6.88 60.9-99 2, 13, 14, 15, 17, 
21, 23, 24, 26 
Insect repellant       
 DEETa China, EU-wide 2.56-3.19 0.61-15.80 65.6-79.5 14, 25 
UV-filter       
 Benzophenone-3 Korea, Spain <0.079-0.904 <0.79-0121 78.2 2, 24 
Steroid hormone       
 Estrone China, France, Germany,  
Italy, Korea, Sweden, US 
0.01-0.17 <0.001-0.08 74.8-87.1 2, 9, 16, 28 
 Estradiol China, France, Germany,  
Italy, Korea, Sweden, US 
0.002-0.05 <0.001-0.007 47-92.6 2, 9, 16, 28 
 17α-Ethynylestradiol China, France, Germany,  
Italy, Sweden, US 
0.001-0.003 <0.001-0.002 43.8 9, 16, 28 
 Estriol China, Korea  0.125 -0.80 0-0 100 2, 16 
Surfactants       
 Nonylphenol China, France, Germany, 
Greece, Italy, Spain, US, WB 
<0.03-101.6 <0.03-7.8 21.7-91.4 4, 9, 15, 16, 17, 
23, 25 
 Octylphenol China, France, Germany, 
Italy, Spain, UK, US 
<0.2-8.7 0.004-1.3 80-99.6 4, 9, 11, 15, 16, 
17, 25 
       
Industrial chemicals       
Plasticizers       
 Bisphenol A China, France, Greece, US, 
WB 
<0.013-2.14 <0.03-1.10 60-95.1 11, 15, 16, 17, 23, 
25, 26 
 DBPa Austria, China ND-11.81 ND-4.13 73.6-75.5 6, 7 
 DEHPa Austria, China, US 0.003-70.0 0.0001-54.0 22.9-97 6, 7, 26 
 DMPa Austria, China ND-6.49 ND-1.52 84.8-93.5 6, 7 
Fire retardant       
 TCEPa EU-wide, Germany 0.06-0.5 0.06-2.4  -105.6- -20.7 14, 18 
 TCPPa EU-wide, Germany 0.18-4 0.1-21 -26.2- -50.0 14, 18 
Pesticide       
Herbicide       
 Atrazine EU-wide, France, Spain, 
Switzerland, WB 
0.02-28 0.004-0.73 <0-50 3, 12, 14, 15, 20, 
25 
 Diuron EU-wide, France, Spain, 
Switzerland 
0.03-1.96 0.002-2.53 19-61.5 3, 12, 14, 15, 20, 
24 
Insectcide       
 Diazinon EU-wide, Spain 0.684 (max) 0.0007-4.16  -111.3 3, 12, 14 
Fungicide       
 Clotrimazole EU-wide, Greece 0.012-0.08 ND-0.005 >80 10, 14, 22 
 Tebuconazole Greece, Spain ND-1.89 0.0005-0.69 19-57 3, 10, 22 
a WB: Western Balkan Region (including Bosnia and Herzegovina, Croatia and Serbia); 
b ND: not detected;  
c When the removal efficiency was not presented in a study, it was calculated using the following equation, removal efficiency (%) = (Cinf -
Ceff)/Cinf×100 (Cinf is the influent concentration of a compound and Ceff is the effluent concentration of a compound); 
d 1. Alder et al., 2010; 2. Behera et al., 2011; 3. Campo et al., 2013; 4. Céspedes et al., 2008; 5.Choi et al., 2008a; 6. Clara et al; 2010;   7. Gao et 
al., 2013; 8. Gracia-Lor et al., 2012; 9. Janex-Habibi et al., 2009;  10.  Kahle et al., 2008; 11. Kasprzyk-Hordern et al., 2009; 12. Köck-
Schulmeyer et al., 2013; 13. Kumar et al., 2010; 14. Loos et al., 2013; 15. Martin et al., 2010; 16. Nie et al., 2012; 17. Pothitou and Voutsa, 2008; 
18. Reemtsma et al., 2008; 19. Santos et al., 2009; 20. Singer et al., 2010;  21. Stamatis and Konstantinou, 2013; 22. Stamatis  et al., 2010; 23. 
Stasinakis et al., 2008; 24. Rosal et al., 2010; 25. Terzić et al., 2008; 26. Yu and Chu, 2009; 27. Zhou et al., 2010; 28. Zorita et al., 2009; 
e Only influent concentrations were provided in the study; 
f Only effluent concentrations were provided in the study.
Table 3 
Human excretion rates of some common pharmaceutical compounds in the aquatic 
environment (adapted from Alder, Hirsch et al., 1999; Huschek et al., 2004; Jjemba, 2006; 
Ternes, 1998; and the range was selected according to Jjemba, 2006) 
Excretion rate Pharmaceutical 
Low (≤5%) Aspirin (acetylsalicylic acid), carbamazepine, gemfibrozil, 
ibuprofen 
Moderately low (6-39%) Diclofenac, metroprolol, primidone, sulfamethoxazole  
Relatively high (40-69%) Bezafibrate, norfloxacin, trimethoprim,  
High (≥ 70%) Amoxicillin, ciprofloxacin, tetracycline 
Table 4  
Occurrence of common micropollutants in surface water from different regions  
Compound 
  Concentration (ng/L) 
Canadaa,1 China2 Costa Ricaa,3 France4 Germany5,6 Greece7 Korea8 Spainb,9 Taiwan10 UK11 US12 PNECb 
Ibuprofen 0.98 (79) ND-1417 5 (36788) ND-8 - 1-67 <15-414 - 5-280 0.3-100 ND-77 5000
Naproxen 1 (87) ND-328 - ND-6.4 - 3-322 - - - 0.3-149 - 37000 
Ketoprofen - - 7 (9808) ND-22.0 - 0.4-39.5 - - 10-190 0.5-14 - 15.6×106 
Diclofenac - - 14 (266) ND-35.0 - 0.8-1043 - - - 0.5-261 - 10000 
Mefenamic acid - - - - - - <30-326 - - 0.3-169 - - 
Carbamazepine 3 (749) - 1 (82) ND-31.6 102-1194 - <4-595 - - 0.5-684 ND-9.6 25000 
Gemfibrozil - - 41 (17036)  - - - - 1.9-3.5 - - 100000 
Atenolol - - - ND-34.0 - - <100-690 - - 1-560 - 10×106 
Sulfamethoxazole 0.2 (284) - 11 (56) ND-5.1 - - - - 0.3-60 0.5-4 ND-38 20000 
Trimethoprim - - - - - - - - 1-2.1 7-122 ND-9.1 1000 
Triclosan 0.4 (25) 35-1023 11 (263) - 124-220 3-39 NDc - - 5-95 ND-9.8 - 
Galaxolide - - - - 35-1814 - - - - - - -
Tonalide - - - - 5-273 - - - - - - - 
Estrone - ND-65 - - - - 3.6-69.1 - - - - 18 
Estradiol - ND-2 - - - - 1.1-10.1 - - - - - 
Ethinylestradiol - ND-1 - - - - ND-1.9 - - - - 0.02 
Estriol - ND-1 - - - - - - - -  149 
Caffeine - - 24 (1121446) - - - - - 1-1813 - ND-225 10×105 
Nonylphenol - 36-33231 - - - 558-2704 115-336 - - - - 330 
Bisphenol A 2.1 (87) 6-881 - - 192-215 55-162 7.5-334 - - 6-68 - 1000 
TCEP - - - - <3-184 - - - - - - - 
TCPP - - - - <4-379 - - - - - - - 
Atrazine - - - - - - - 11 (39) - - - 2000 
Diazinon - - - - - - - 10(216) - - - - 
Diuron - - - - - - - 72(408) - - - 1800 
 
a. The data presented here represent median concentration with maximum concentration in the brackets; 
b. PNEC: Predicted no effect concentration (Data derived from Fromme et al., 2002, Köck-Schulmeyer et al., 2013; Lin et al., 2008 and Loos et al., 2007); 
1. Kleywegt et al., 2011; 2. Peng et al., 2008; 3. Spongberg et al., 2011; 4. Vulliet et al., 2011; 5. Regnery and Püttmann, 2010; 6. Reinstorf et al., 2008; 7. Stasinakis 
et al., 2012; 8. Kim et al., 2009c; 9. Köck-Schulmeyer et al., 2013; 10. Lin et al., 2011; 11. Kasprzyk-Hordern et al., 2009; 12.  Wang et al., 2011. 
Table 5  
Occurrence of selected micropollutants in groundwater from different regions  
Compound 
Concentrations (ng/L) 
Europea,1 Franceb,2 Germanyc,3,4,5 Spaind,6,7 USb,c,8,9,10 PNECe 
Ibuprofen 3 (395) 0 - 185 (0-185) ND, 3110 5000 
Naproxen - 1.2 - 204 (145-263) - 37000 
Ketoprofen 26 (2886) 2.8 - - - 15.6× 106 
Diclofenac 0 (24) 9.7 3050 256 (35-477) - 10000 
Carbamazepine 12 (390) 10.4 <50, 2325  - 40 (420) 25000 
Gemfibrozil - - - 165.3 (12-574) - 100000 
Bezafibrate - 0 112 - - -
Atenolol - 5.5  60.8 (18-106) - 10 × 106
Sulfamethoxazole 2 (38) 3.0 - 47.57 (2-117) 1110, 160 (170) 20000 
Trimethoprim - 1.4 - - - 1000 
Caffeine 13 (189) - - 63.56 (4-505) 130, 170 (290) 10 × 105 
Triclosan 0 (9) - 39.8 (2-118) 53 - 
Nonylphenol 83 (3850) - - - - 330 
Bisphenol A 79 (2299) - - - 2550 1000 
Estrone 0 (4) 0.7 - - 79 18 
Estradiol - 0.4 - - 147 - 
Ethinylestradiol - 1.2 - - 230 0.02 
Estriol - - - - 1661 149
TCEP - - 4-51 - - - 
TCPP - - 14-355 - - - 
Atrazine - - - 36 (756) - 2000 
Diazinon - - - 5.3 (30.8) - - 
Diuron - - - 8.8 (178) - 1800 
 
a. average concentration with maximum concentration in the brackets; 
b. average concentration; 
c. maximum concentration; 
d. average concentration with minimum and maximum concentrations in the brackets. 
e. PNEC: Predicted no effect concentration (Data derived from Fromme et al., 2002, Loos et al., 2007 and Lin et al., 2008). 
1. Loos et al., 2010; 2. Vulliet and Cren-Olivé, 2011;  3. Maeng et al., 2010; 4. Müller et al., 2012; 5. Stepien et al., 2013; 6. Postigo et al., 2010; 
7. Teijon et al., 2010; 8. Barnes et al., 2008; 9. Fram and Belitz, 2011; 10. Karnjanapiboonwong et al., 201
 
Table 6  
Simple classification of micropollutants based on removal efficiency
Degree of removal Compounds 
Poorly removed (<40%) carbamazepine, metoprolol, diclofenac 
Moderately removed  
(40-70%) 
trimethoprim, ketoprofen, clofibric acid, sulfamethoxzole, 
atenolol, nonylphenol,  




Table 7  
Removals of some micropollutants during coagulation-flocculation processes 
Coagulant Dosage with pH value 
presented in the 
parentheses 
Compound Removal  
(%) 
References 
FeCl3/Al2(SO4)3 25, 50 ppm (7) Ibuprofen 12.0 ± 4.8 Suárez et al., 
2009) 
Diclofenac 21.6 ± 19.4 
Naproxen 31.8 ± 10.2 
Carbamazepine 6.3 ± 15.9 
Sulfamethoxazole 6.0 ± 9.5 
Tonalide 83.4 ± 14.3 
Galaxolide 79.2 ± 9.9 




Al2(SO4)3 200 mg/L (7) Aldrin 46 Thuy et al., 
2008 
100 mg/L (7) Bentazon 15 


















Table 8  
Removals of some micropollutants during adsorption process 
Adsorbent Dosage (mg/L) Compound Removal (%) References 
PAC 8, 23, 43 
 
Diclofenac 96, 98, 99 Kovalova et al., 
2013 
Carbamazepine 98, 99, 100 
Propranolol >91, >94, >94 
Sulfamethoxazole 2, 33, 62 






29 g/70.6 mL bed 
volume 
Galaxolide 79 Hernández-Leal et 
al., 2011 
Tonalide 67 




empty bed contact 
time :15 min 









Removals of some micropollutants during ozonation and AOPs 
Treatment Compound Removal (%) 
O3 (5 mg/L): 15 min 







O3 (15 mg/L) 




O3 (5 mg/L)+H2O2 (3.5 mg/L) 










UV254: 10 min 






UV254 + H2O2 (50 mg/L): 
10min, 30 min 
(De la Cruz et al., 2012) 
Ibuprofen 100 (10 min), 100 (30 min) 
Diclofenac 100 (10 min), 100 (30 min) 
Carbamazepine 75 (10 min), 100 (30 min) 
Sulfamethoxazole 98 (10 min), 100 (30 min) 
Atrazine 100 (10 min), 100 (30 min) 
Table 10  
Removals of some micropollutants during membrane processes 
Membrane Water type Membrane conditions Compound Removal (%)  Ref 
UF Synthetic water  
 
PESa flat-sheet, 100  kDa; TMP = 0.5 ± 0.01 bar Ibuprofen 7 Jermann et al., 
2009 
RC4a flat-sheet; TMP = 0.5 ± 0.01 bar  Minor  
PES flat-sheet, 100 kDa; TMP = 0.5 ± 0.01 bar Estradiol Up to 80 
RC4 flat-sheet; TMP = 0.5 ± 0.01 bar  Up to 25 
NF WWTP effluent 
 




Flat-sheet, area 3.5 m2; TMP = 0.3 or 0.7 bar Naproxen 60 
Flat-sheet, area 3.5 m2; TMP = 0.3 or 0.7 bar Carbamazepine Minor  
Filmtec NF90; TMP = 345 kPa  91 
Filmtec NF200; TMP = 483 kPa Acetaminophen 23 
Filmtec NF200; TMP = 483 kPa EE2a 90 
Filmtec NF90; TMP = 345 kPa Atrazine 97 






Filmtec TW30; TMP = 9.5–10.2 bar Ibuprofen >99 
Filmtec TW30; TMP = 9.5–10.2 bar Sulfonamides >93 
Filmtec TW30; TMP = 9.5–10.2 bar Diclofenac 95 
Filmtec TW30; TMP = 9.5–10.2 bar Macrolides >99 
Filmtec TW30; TMP = 9.5–10.2 bar Bisphenol A >99 
1. Jermann et al., 2009; 2. Röhricht et al., 2009; 3. Yangali-Quintanilla et al., 2011; 4. Sahar et al., 2011 
a PES: polyethersulfone; RC: regenerated cellulose; EE2: 17α-ethynilestradiol 
 
Table 11  
Removals of some micropollutants during MBR processes 
Water type Membrane & experimental conditions Compounds Removal (%) References 
Raw wastewater Full-scale HF (Koch Puron)*; 
MA# 235 m2; Pore size 0.1-0.2 μm; 
SRT: 10-15 d; HRT: 1 d; 
MLSS: 7.5-8.5 g/L 
 





Estrone,  ~100 
Estriol ~100 
BisphenolA ~100 
Synthetic wastewater Lab-scale Polyvinylidene fluoride HF; 
MA 0.2 m2; Pore size 0.4 μm; 
HRT: 1 d or 3 d; 
MLSS: 2.3-4.6 g/L 
Ibuprofen ~100 Bo et al., 2009 
Diclofenac Minor  
Carbamazepine Minor  
Synthetic wastewater Lab-scale Polyethylene hollow fibre;  
MA 0.2 m2; Pore size 0.4 μm; 
HRT: 8, 6 and 4 h; SRT: 350 d; 
MLSS: 5.2-13.7 g/L 
BisphenolA >93.7 Chen et al., 2008 
Hospital effluent Pilot-scale Submerged PES UF flat sheet; 
Area 7 m2; Pore size 38 nm; 
SRT: 30-50 d; 
MLSS: 2 g/L 




Synthetic wastewater Lab-scale submerged HF UF module; 
MA 0.047 m2; Pore size 0.04 μm; 
SRT:70 d; HRT: 24 h; 
MLSS: 8.6-10 g/L 
Ibuprofen  96.7 ± 0.7 Tadkaew et al., 2011 
Diclofenac 17.3 ± 4.2 
Carbamazepine 13.4 ± 4.3 
Sulfamethoxazole 91.9 ± 0.6 
17β-estradiol >99.4 
17α-ethynylestradiol 93.5  ± 1.2 
Bisphenol A 90.4 ± 3.1 
Nonylphenol 99.3 ± 0.2 
Atrazine 4.4 ± 3.7 
Hospital effluent Full-scale 5 Kubota EK 400 flat sheet; 
Q 130 m/d 
Ibuprofen >80 Beier et al., 2011 
Carbamazepine <20 
Diclofenac <20 
*hollow fibre; #MA: membrane area.
Table 12  
Removals of some micropollutants during attached growth treatment processes 




Media height: 80cm; 
Diameter: 22.5 cm; 
EBCT: 18 min 






Media: wheel shaped plastic elements E1 62.2 Balest et al., 2008 
E2 68 




Volume: 1.4 L 
HRT: 4.3 d, 1 d, 0.3 d 
EE2 96 (4.3 d) Forrez et al., 2009 
EE2 81 (1 d) 




Volume: 2.5 L 




Volume: 5 L 
Batch experiments for 24 hours 




Memfenamic acid >80 
Clofibric acid >60 
a. BAC: biological activated carbon; SBBGR: sequencing batch biofilter granular reactor; ASFBBR: aerated submerged fixed bed bioreactor; 
MBBR: moving bed biofilm reactor. K1: A type of plastic carrier rings (model K1, AnoxKaldnes, Sweden); BMBBC: Bioplastic-based moving 
bed biofilm carriers; OC: oseltamivir carboxylate;   
b. In this study, only mineralization of the selected compounds was evaluated. Total removal could be higher due to other removal pathway
Table 13  
Comparison of micropollutants removal effectiveness in different WWTPs 
Compounds 
Removals (%) in different types of WWTPs 
Conventional1 Low-cost2 Advanced3 
Ibuprofen 71 – 99 38 – 99 >35 – 99 
Diclofenac 5 – 81 ~0 – 88 78 – >99 
Ketoprofen 11 – 94 ~0 – 88 83 –99 
Carbamazepine 10 – 59 ~0 – 51 68 – 99 
Estrone 75 – 87 60 – 78 >50 – >99 
Bisphenol A 60 – 95 23 – 73 >58 – >98 
Nonylphenol 22 – 93 56 – 85 48 – >99 
1. Alder et al., 2010; Behera et al., 2011; Céspedes et al., 2008; Choi K. et al., 2008; Gracia-
Lor et al., 2012; Janex-Habibi et al., 2009; Kasprzyk-Hordern et al., 2009; Kumar et al., 
2010; Martin et al., 2010; Nie et al., 2012; Pothitou and Voutsa, 2008; Santos et al., 2009; 
Singer et al., 2010; Stasinakis et al., 2008; Yu and Chu, 2009 
2. Camacho-Muñoz et al., 2012; Hijosa-Valsero et al., 2010. 
3. Gracia-Lor Rosal et al., 2010; Rosal et al., 2010; Schaar et al., 2010; Sui et al; 2010; Yang 
et al., 2011; Zhou et al., 2010;   Zorita et al., 2009;    
 
Table 14  
Assessment of different treatment processes for micropollutants removal 
Technique 
Common removal efficiencya Major  factors 
Disadvantage/problems Residues 
P PCP SH IC Process-specific MP-related 





 Molecular size 
 Ineffective MP removal 
 Large amount of sludge 
 Introduction of coagulant salts 
in the aqueous phase 
Sludge 
AC M-H M-H H M-H  Adsorbent properties 
 Dosage 




 Molecular size 
 Structure 
 Functional group 
 Relatively high financial costs 
 Lower efficiency in the presence 
of NOMs 
 Need for regeneration 





M-H M-H H M-H  Dosage 
 pH 






 High energy consumption 
 Formation of byproducts 





NF M-H H M-H M-H  Membrane properties 
 pH 
 transmemrane pressure 
 feed quality 
 Hydrophobicity 
 Molecular size 
 High energy demand 
 Membrane fouling 
 Disposal of concentrate 




RO M-H H H H  Membrane properties 
 pH 
 transmemrane pressure 
 feed quality 
 Hydrophobicity 
 Molecular size 
 High energy consumption 
 Disposal of concentrate 
 Corrosive nature of the finished 
water 
Concentrate 
Activated sludge L-H M-H M-H L-H  SRT 
 HRT 
 Organic loading 




 Micropolluants sorbed onto 
sewage sludge may increase the 
environmental risk  
 Disposal of sludge 
Wasted sludge 
MBR L-H M-H H M-H  SRT 
 HRT 
 Organic load 
 Redox conditions 
 Hydrophobicity 
 Biodegradability 
 Moderately high energy 
consumption 
 Inconsistent removal of polar 
and resistant compounds 
 Membrane fouling 
 Micropollutants tend to sorb less 
onto the aged MBR sludge 
 
Wasted sludge 
Attached growth L-H M-H M-H M-H  HRT 
 Organic loading 
 Redox conditions 
 Hydrophobicity 
 Biodegradability 
 Long start-up time 
 Difficulty in control of biofilm 
thickness 
Wasted sludge 
a. P: pharmaceutical; PCP: personal care product; SH: steroid hormone; IC: industrial chemical; L: low; M: medium; H: high 
 
